
<html lang="en"     class="pb-page"  data-request-id="556bb813-a945-405f-8f72-55373e77584d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-12;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00304;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate" /></meta><meta name="dc.Creator" content="Harrie J. M.  Gijsen" /></meta><meta name="dc.Creator" content="Sergio A.  Alonso de Diego" /></meta><meta name="dc.Creator" content="Michel  De Cleyn" /></meta><meta name="dc.Creator" content="Aránzazu  García-Molina" /></meta><meta name="dc.Creator" content="Gregor J.  Macdonald" /></meta><meta name="dc.Creator" content="Carolina  Martínez-Lamenca" /></meta><meta name="dc.Creator" content="Daniel  Oehlrich" /></meta><meta name="dc.Creator" content="Hana  Prokopcova" /></meta><meta name="dc.Creator" content="Frederik J. R.  Rombouts" /></meta><meta name="dc.Creator" content="Michel  Surkyn" /></meta><meta name="dc.Creator" content="Andrés&#xA;A.  Trabanco" /></meta><meta name="dc.Creator" content="Sven  Van Brandt" /></meta><meta name="dc.Creator" content="Dries  Van den Bossche" /></meta><meta name="dc.Creator" content="Michiel  Van Gool" /></meta><meta name="dc.Creator" content="Nigel  Austin" /></meta><meta name="dc.Creator" content="Herman  Borghys" /></meta><meta name="dc.Creator" content="Deborah  Dhuyvetter" /></meta><meta name="dc.Creator" content="Diederik  Moechars" /></meta><meta name="dc.Description" content="In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the pKa of the amidine group, resulting in compound 2 that showed excellent in vivo effi..." /></meta><meta name="Description" content="In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the pKa of the amidine group, resulting in compound 2 that showed excellent in vivo effi..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 29, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00304" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00304" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00304" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00304" /></link>
        
    
    

<title>Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00304" /></meta><meta property="og:title" content="Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0009.jpeg" /></meta><meta property="og:description" content="In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the pKa of the amidine group, resulting in compound 2 that showed excellent in vivo efficacy, lowering Aβ levels in brain and CSF. However, a suboptimal cardiovascular safety margin, based on QTc prolongation, prevented further progression. Further optimization resulted in the replacement of the 2-fluoro substituent by a CF3-group, which reduced hERG inhibition. This has led to compound 3, with an improved cardiovascular safety margin and sufficiently safe in GLP toxicity studies to progress into clinical trials." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00304"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00304">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00304&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00304&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00304&amp;href=/doi/10.1021/acs.jmedchem.8b00304" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5292-5303</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00250" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00384" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/acs.jmedchem.8b01859"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Harrie J. M. Gijsen</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Harrie J. M. Gijsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +32 14 606830. E-mail: <a href="/cdn-cgi/l/email-protection#c7afa0aeadb4a2a987aeb3b4e9ada9ade9a4a8aa"><span class="__cf_email__" data-cfemail="bad2ddd3d0c9dfd4fad3cec994d0d4d094d9d5d7">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Harrie+J.+M.++Gijsen">Harrie J. M. Gijsen</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sergio A. Alonso de Diego</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sergio A. Alonso de Diego</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen−Cilag SA, C/Jarama 75A, 45007 Toledo, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sergio+A.++Alonso+de+Diego">Sergio A. Alonso de Diego</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michel De Cleyn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michel De Cleyn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michel++De+Cleyn">Michel De Cleyn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Aránzazu García-Molina</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aránzazu García-Molina</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen−Cilag SA, C/Jarama 75A, 45007 Toledo, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ar%C3%A1nzazu++Garc%C3%ADa-Molina">Aránzazu García-Molina</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregor J. Macdonald</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregor J. Macdonald</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregor+J.++Macdonald">Gregor J. Macdonald</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carolina Martínez-Lamenca</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carolina Martínez-Lamenca</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carolina++Mart%C3%ADnez-Lamenca">Carolina Martínez-Lamenca</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Oehlrich</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Oehlrich</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Oehlrich">Daniel Oehlrich</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3392-1952" title="Orcid link">http://orcid.org/0000-0002-3392-1952</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hana Prokopcova</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hana Prokopcova</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hana++Prokopcova">Hana Prokopcova</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Frederik J. R. Rombouts</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frederik J. R. Rombouts</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Frederik+J.+R.++Rombouts">Frederik J. R. Rombouts</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1986-0476" title="Orcid link">http://orcid.org/0000-0003-1986-0476</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michel Surkyn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michel Surkyn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Surkyn">Michel Surkyn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrés A. Trabanco</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrés A. Trabanco</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen−Cilag SA, C/Jarama 75A, 45007 Toledo, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A9s%0AA.++Trabanco">Andrés A. Trabanco</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4225-758X" title="Orcid link">http://orcid.org/0000-0002-4225-758X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sven Van Brandt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sven Van Brandt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sven++Van+Brandt">Sven Van Brandt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dries Van den Bossche</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dries Van den Bossche</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dries++Van+den+Bossche">Dries Van den Bossche</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michiel Van Gool</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michiel Van Gool</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Medicinal Chemistry, Janssen Research & Development, Janssen−Cilag SA, C/Jarama 75A, 45007 Toledo, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michiel++Van+Gool">Michiel Van Gool</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nigel Austin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nigel Austin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nigel++Austin">Nigel Austin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Herman Borghys</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Herman Borghys</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Herman++Borghys">Herman Borghys</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Deborah Dhuyvetter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Deborah Dhuyvetter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Discovery Sciences, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Deborah++Dhuyvetter">Deborah Dhuyvetter</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Diederik Moechars</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diederik Moechars</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Neuroscience Biology, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diederik++Moechars">Diederik Moechars</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00304&amp;href=/doi/10.1021%2Facs.jmedchem.8b00304" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5292–5303</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 29, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 February 2018</li><li><span class="item_label"><b>Published</b> online</span>29 May 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 June 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00304" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00304</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5292%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHarrie%2BJ.%2BM.%2BGijsen%252C%2BSergio%2BA.%2BAlonso%2Bde%2BDiego%252C%2BMichel%2BDe%2BCleyn%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D12%26contentID%3Dacs.jmedchem.8b00304%26title%3DOptimization%2Bof%2B1%252C4-Oxazine%2B%25CE%25B2-Secretase%2B1%2B%2528BACE1%2529%2BInhibitors%2BToward%2Ba%2BClinical%2BCandidate%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5303%26publicationDate%3DJune%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00304"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1949</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00304" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Harrie&quot;,&quot;last_name&quot;:&quot;J. M. Gijsen&quot;},{&quot;first_name&quot;:&quot;Sergio&quot;,&quot;last_name&quot;:&quot;A. Alonso de Diego&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;De Cleyn&quot;},{&quot;first_name&quot;:&quot;Aránzazu&quot;,&quot;last_name&quot;:&quot;García-Molina&quot;},{&quot;first_name&quot;:&quot;Gregor&quot;,&quot;last_name&quot;:&quot;J. Macdonald&quot;},{&quot;first_name&quot;:&quot;Carolina&quot;,&quot;last_name&quot;:&quot;Martínez-Lamenca&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Oehlrich&quot;},{&quot;first_name&quot;:&quot;Hana&quot;,&quot;last_name&quot;:&quot;Prokopcova&quot;},{&quot;first_name&quot;:&quot;Frederik&quot;,&quot;last_name&quot;:&quot;J. R. Rombouts&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Surkyn&quot;},{&quot;first_name&quot;:&quot;Andrés\nA.&quot;,&quot;last_name&quot;:&quot;Trabanco&quot;},{&quot;first_name&quot;:&quot;Sven&quot;,&quot;last_name&quot;:&quot;Van Brandt&quot;},{&quot;first_name&quot;:&quot;Dries&quot;,&quot;last_name&quot;:&quot;Van den Bossche&quot;},{&quot;first_name&quot;:&quot;Michiel&quot;,&quot;last_name&quot;:&quot;Van Gool&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;Austin&quot;},{&quot;first_name&quot;:&quot;Herman&quot;,&quot;last_name&quot;:&quot;Borghys&quot;},{&quot;first_name&quot;:&quot;Deborah&quot;,&quot;last_name&quot;:&quot;Dhuyvetter&quot;},{&quot;first_name&quot;:&quot;Diederik&quot;,&quot;last_name&quot;:&quot;Moechars&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;5292-5303&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00304&quot;},&quot;abstract&quot;:&quot;In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the pKa of the amidine group, resulting in compound 2 that showed excellent in vivo efficacy, lowering Aβ levels in brain and CSF. However, a suboptimal cardiovascular safety margin, based on QTc prolongation, prevented further progression. Further optimization resulted in the replacement of the 2-fluoro substituent by a CF3-group, which reduced hERG inhibition. This has led to compound 3, with an improved cardiovascular safety margin and sufficiently safe in GLP toxicity studies to progress into clinical trials.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00304&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00304" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00304&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00304" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00304&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00304" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00304&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00304&amp;href=/doi/10.1021/acs.jmedchem.8b00304" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00304" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00304" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00304%26sid%3Dliteratum%253Aachs%26pmid%3D29809004%26genre%3Darticle%26aulast%3DGijsen%26date%3D2018%26atitle%3DOptimization%2Bof%2B1%252C4-Oxazine%2B%25CE%25B2-Secretase%2B1%2B%2528BACE1%2529%2BInhibitors%2BToward%2Ba%2BClinical%2BCandidate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D12%26spage%3D5292%26epage%3D5303%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291697" title="Safety">Safety</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/jmcmar.2018.61.issue-12/20180628/jmcmar.2018.61.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In previous studies, the introduction of electron withdrawing groups to 1,4-oxazine BACE1 inhibitors reduced the p<i>K</i><sub>a</sub> of the amidine group, resulting in compound <b>2</b> that showed excellent in vivo efficacy, lowering Aβ levels in brain and CSF. However, a suboptimal cardiovascular safety margin, based on QTc prolongation, prevented further progression. Further optimization resulted in the replacement of the 2-fluoro substituent by a CF<sub>3</sub>-group, which reduced hERG inhibition. This has led to compound <b>3</b>, with an improved cardiovascular safety margin and sufficiently safe in GLP toxicity studies to progress into clinical trials.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26231" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26231" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is the most common form of dementia, causing progressive decline of cognitive function, behavioral changes, and eventually death due to neuronal loss. It is affecting over 44 million people worldwide, and numbers are predicted to increase even further over the coming years, creating a huge physical, social, and economic burden for patients and their families.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The main pathological hallmarks are intracellular neurofibrillary tangle and extracellular plaque deposition. These are composed of hyperphosphorylated tau protein and amyloid-β (Aβ) peptides, respectively.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Supported by genetic and histopathological data, the amyloid-β cascade hypothesis states that disturbance of the equilibrium between the production and clearance of toxic Aβ peptides causes the onset of the disease.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The first and rate-limiting step in the generation of Aβ peptides is the cleavage of amyloid precursor protein (APP) by the β-secretase aspartyl protease 1 (BACE1). Therefore, inhibition of BACE1 is one of the most compelling approaches in the treatment of AD,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> resulting in a highly competitive landscape with several compounds progressing in clinical trials.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In these trials, BACE1 inhibitors have been shown to efficiently lower Aβ levels but so far have failed to slow the disease progression in mild-to-moderate or even prodromal AD patients, highlighted by the recent termination of the EPOCH and APECS trials with verubecestat.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> To achieve therapeutic efficacy with a BACE1 inhibitor, treatment may need to start well before the disease becomes symptomatic, in a preventive approach.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This will require highly safe compounds, hence our continued interest in novel chemotypes.</div><div class="NLM_p">In a recent publication, we have described the design and optimization of a series of 1,4-oxazine BACE1 inhibitors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The decoration of the 1,4-oxazine ring with electron withdrawing groups to reduce the amidine p<i>K</i><sub>a</sub> resulted in orally bioavailable, centrally active BACE1 inhibitors capable of lowering brain and cerebrospinal fluid (CSF) Aβ levels in mouse and dog, respectively.</div><div class="NLM_p">From these efforts, the 2-fluoro-1,4-oxazine <b>2</b> emerged as a very effective agent in lowering CSF Aβ levels in dogs (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The introduction of the 2-fluoro group in <b>1</b> reduced the p<i>K</i><sub>a</sub> of the amidine basic moiety by over 1 log unit, resulting in reduced P-gp efflux and a slight reduction in hERG affinity (8.3 μM binding for <b>2</b> vs 5 μM binding for <b>1</b>). This however did not result in an improvement in the functional hERG channel patch-clamp assay, where both compounds showed a similar level of inhibition of ∼50% at 3 μM concentration.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Different generations of 1,4-oxazine BACE1 inhibitors, improving P-gp efflux and the cardiovascular safety profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a subsequent in vivo model using anesthetized guinea-pigs,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> compound <b>2</b> dose dependently prolonged the QTcB interval starting at a plasma concentration (<i>C</i><sub>max</sub>) of 475 ng/mL. The no observed adverse effect level (NOAEL) was determined at 170 ng/mL, giving an insufficient safety margin over the EC<sub>50</sub> concentration of 20 ng/mL, as determined in dog.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Although it is currently unknown how much reduction in Aβ levels will be therapeutically beneficial, a 50% reduction in Aβ levels is the minimum targeted in most ongoing clinical trials,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and a relevant BACE clinical candidate should be able to achieve this with sufficient safety margin.</div><div class="NLM_p last">In this article, we describe the optimization of <b>2</b> toward molecules combining good in vivo efficacy with a sufficient cardiovascular safety margin. This included further investigation of other electron-withdrawing substituents on the 1,4-oxazine ring and more extensive variations on the distal heteroaromatic ring (B). From this exploration, <b>3</b> has emerged as an oxazine-containing BACE1 inhibitor combining all the desired properties.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our initial studies had indicated an influence of the B-ring substitution on hERG binding and inhibition. To further investigate this finding, a small set of close analogues of <b>2</b> containing the 2-fluoro-1,4-oxazine amidine warhead and the original cyanopyridyl B-ring containing ortho-substituents was prepared.</div><div class="NLM_p">Analogues <b>4</b> and <b>5</b> indeed showed an improvement in hERG binding and in the more relevant patch-clamp functional assays (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, when dosed to mice, no brain levels were detected at 2 and 4 h for either of the two compounds after an oral administration of a 30 mg/kg (<b>4</b>) or 10 mg/kg (<b>5</b>) dose. This can be attributed to an increased efflux for <b>4</b> and poor bioavailability for <b>5</b>. While the latter compound was sufficiently stable when tested in mouse liver microsomes (mLM), a significant instability in mouse hepatocytes was observed (55% turnover after 60 min of incubation at 1 μM), explaining the low plasma levels in mice (38 ng/mL after 4 h).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Profile of 2-Fluoro-1,4-oxazine Analogues<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0005.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1 IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">18.4</td><td class="colsep0 rowsep0" align="left">10.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hAβ42 cell IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">12.2</td><td class="colsep0 rowsep0" align="left">15.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG PC (% inh. @ 3 μM)</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hLM (% metabolized @ 15 min)</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mLM (% metabolized @ 15 min)</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mHepatocytes (% metabolized @ 60 min)</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> +Elacridar (nm/s)</td><td class="colsep0 rowsep0" align="left">183</td><td class="colsep0 rowsep0" align="left">69.5</td><td class="colsep0 rowsep0" align="left">94.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> −Elacridar (nm/s)</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">10.5</td><td class="colsep0 rowsep0" align="left">30.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> ratio</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">3.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_001.pdf" class="ext-link">Supporting Information</a> for assay details. The IC<sub>50</sub> values for the enzymatic BACE1 and hAß42 cellular assays represent the mean values of at least two independent experiments. n.d.: not determined</p></div></div></div><div class="NLM_p">The challenges in finding an optimal profile via a suitable combination of the 2-fluoro-1,4-oxazine amidine warhead and a substituted B-ring made us revisit alternatively substituted oxazine warheads described in our previous paper.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Matched pair analysis of a set of 2-fluoro- and 2-CF<sub>3</sub>–1,4-oxazine analogues bearing a standard set of substituted B-rings indicated a reduced hERG inhibition potential for the 2-CF<sub>3</sub>–1,4-oxazine analogues despite a moderate increase in lipophilicity of 0.3 log units for the trifluoromethyl-substituted analogues (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. hERG Patch-Clamp Inhibition: Matched Pair Analysis of 2-Fluoro- and 2-CF<sub>3</sub>–1,4-Oxazine Analogues</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0006.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">The synthetic route toward the synthesis of compounds <b>1</b>, <b>2</b>, and <b>4</b>–<b>7</b> has been described before.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The synthesis of CF<sub>2</sub>- and CF<sub>3</sub>-substituted analogues is depicted in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The previously described synthesis route toward the 2-CF<sub>3</sub>–1,4-oxazine derivatives involved the introduction of the CF<sub>3</sub> substituent by addition of Ruppert–Prakash reagent (TMSCF<sub>3</sub>) to diketo oxazine <b>11</b> and subsequent removal of the hydroxyl group in <b>12</b> via chlorination to <b>13</b>, followed by a zinc mediated reductive dehalogenation toward <b>14</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Thionation of the amide with P<sub>2</sub>S<sub>5</sub>, followed by aminolysis of the thioamide delivered the corresponding amidine derivative <b>15</b>. This was next converted to the aniline <b>16</b> by using a copper-catalyzed reaction employing sodium azide, which was further elaborated to final products <b>17</b> via amide formation with the corresponding carboxylic acids using the coupling reagent 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride (DMTMM).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Recently, an alternative route for the multigram synthesis of compounds with this warhead has been published.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 2-CF<sub>3</sub>–1-4-Oxazines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) TMSCF<sub>3</sub>, TBAT, THF, 0 °C to rt, 20 min; (b) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (c) Zn, AcOH, 100 °C, 20 min; (d) P<sub>2</sub>S<sub>5</sub>, THF, 70 °C, 2–4 h; (e) 7N NH<sub>3</sub> in MeOH, 80 °C, 2 h; (f) NaN<sub>3</sub>, CuI, DMEDA, Na<sub>2</sub>CO<sub>3</sub>, DMSO, 110 °C, 4h; (g) RCOOH, DMTMM, MeOH, 0 °C to rt, 2–24 h; (h) 5-pyrimidinylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub> satd aq, 1,4-dioxane, 80 °C, 2 h; (i) (<i>E</i>)-(2-(5-cyanopyridin-2-yl)vinyl)boronic acid pinacol ester, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub> satd aq, 1,4-dioxane, 140 °C, 0.5 h, μw; (j) 2-bromo-3-cyanopyridine, dppf, Pd<sub>2</sub>(dba)<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 160 °C, 1 h, μw. Compound <b>18</b> was prepared as a racemate, starting from racemic <b><b>15</b></b>.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-CF<sub>2</sub>- and 2-CHF<sub>2</sub>–1,4-Oxazines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Zn–Cu, AcOH, rt, 16 h; (b) P<sub>2</sub>S<sub>5</sub>, THF, 70 °C, 2–4 h; (c) 7N NH<sub>3</sub> in MeOH, 80 °C, 2 h; (d) NaN<sub>3</sub>, CuI, DMEDA, Na<sub>2</sub>CO<sub>3</sub>, DMSO, 110 °C, 3 h; (e) 5-methoxy-2-pyrazinecarboxylic acid, DMTMM, MeOH, 0 °C, 2–6 h; (f) H<sub>2</sub>, Pd/C, thiophene, EtOAc, rt, 16 h.</p></p></figure><div class="NLM_p">Alternatively, Suzuki coupling reaction of bromoarene <b>15</b> with 5-pyrimidinylboronic acid or <i>E</i>-2-(5-cyanopyridin-2-yl)vinyl)boronic acid pinacol ester led to the analogues <b>18</b> and <b>19</b>, respectively. Buchwald coupling between aniline <b>16</b> and 2-bromo-3-cyanopyridine yielded the bisaryl aniline derivative <b>20</b>.</div><div class="NLM_p">Over the course of the project, the transformation from <b>13</b> to <b>14</b> had been carried out numerous times with significant amounts of elimination product <b>21</b> observed. (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). After optimization, the ratio <b>14</b> to <b>21</b> was found to be de dependent on the zinc source and reaction conditions. Thus, the use of fresh metallic zinc dust in acetic acid at 100 °C was selective for the reductive dehalogenation (<b>14</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), whereas using zinc–copper couple in acetic acid at room temperature resulted in almost quantitative formation of the elimination product <b>21</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p">The difluoroalkene intermediate <b>21</b> was also elaborated into the corresponding BACE1 inhibitor <b>24</b> in a similar reaction sequence as described for <b>17</b>. Moreover, hydrogenation of the double bond in <b>24</b> yielded the CHF<sub>2</sub> substituted analogue <b>25</b> as a single diastereomer. The stereochemistry of the CHF<sub>2</sub> substituent in <b>25</b> was confirmed via <sup>1</sup>H-NOESY and <sup>19</sup>F-<sup>1</sup>H NOESY experiments indicating a perfect fit with MOE-calculated distances. Profiling of these derivatives allowed a match pair comparison of additional small changes in substitution pattern of the 1,4-oxazines, and the results are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Profiles of F, CF<sub>3</sub>, CF<sub>2</sub>═, and CHF<sub>2</sub> Analogues<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0007.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>7</b></th><th class="colsep0 rowsep0" align="center"><b>10</b></th><th class="colsep0 rowsep0" align="center"><b>24</b></th><th class="colsep0 rowsep0" align="center"><b>25</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1 IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">12.0</td><td class="colsep0 rowsep0" align="left">29.5</td><td class="colsep0 rowsep0" align="left">151.4</td><td class="colsep0 rowsep0" align="left">11.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hAβ42 cell IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">13.2</td><td class="colsep0 rowsep0" align="left">27.7</td><td class="colsep0 rowsep0" align="left">35.1</td><td class="colsep0 rowsep0" align="left">4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG PC (% inh. @ 3 μM)</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">nd</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> +Elacridar (nm/s)</td><td class="colsep0 rowsep0" align="left">201</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">216</td><td class="colsep0 rowsep0" align="left">166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> −Elacridar (nm/s)</td><td class="colsep0 rowsep0" align="left">176</td><td class="colsep0 rowsep0" align="left">137</td><td class="colsep0 rowsep0" align="left">86.3</td><td class="colsep0 rowsep0" align="left">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> ratio</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,b</sub> (%)</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u</sub> plasma mouse (%)</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">15.5</td><td class="colsep0 rowsep0" align="left">14.6</td><td class="colsep0 rowsep0" align="left">27.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p<i>K</i><sub>a</sub></td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">7.8</td><td class="colsep0 rowsep0" align="left">7.9</td><td class="colsep0 rowsep0" align="left">8.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Aβ42 reduction in mice (%) after 1, 2, and 4 h at 10 mg/kg po</td><td class="colsep0 rowsep0" align="left">39, 65, 62</td><td class="colsep0 rowsep0" align="left">23, 37, 29</td><td class="colsep0 rowsep0" align="left">6, 7 (2, 4 h)</td><td class="colsep0 rowsep0" align="left">11, 38, 40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>p</sub> (4 h)</td><td class="colsep0 rowsep0" align="left">0.60 ± 0.10</td><td class="colsep0 rowsep0" align="left">1.81 ± 0.93</td><td class="colsep0 rowsep0" align="left">0.97 ± 0.15</td><td class="colsep0 rowsep0" align="left">0.40 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Estimated <i>K</i><sub>p(u,u)</sub> (4 h)</td><td class="colsep0 rowsep0" align="left">0.09 ± 0.01</td><td class="colsep0 rowsep0" align="left">0.23 ± 0.12</td><td class="colsep0 rowsep0" align="left">0.11 ± 0.02</td><td class="colsep0 rowsep0" align="left">0.07 ± 0.01</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">See <a href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_001.pdf" class="ext-link">Supporting Information</a> for assay details. The IC<sub>50</sub> values for the enzymatic BACE1 and hAß42 cellular assays represent the mean values of at least two independent experiments.</p></div></div></div><div class="NLM_p">A 12-fold decrease in potency was observed for the CF<sub>2</sub>-olefinic amidine <b>24</b> when compared to the 2-F-substituted oxazine <b>7</b> (BACE1 IC<sub>50</sub> of 12 nM for <b>7</b> vs 151 nM for <b>24</b>): Furthermore, compound <b>24</b> showed only a modest Aβ42 reduction in mice at 10 mg/kg po. While the cellular activity for the CHF<sub>2</sub>-analogue <b>25</b> improved 3-fold when compared to <b>7</b>, an increased efflux ratio was also measured in the LLC-MDR1 cell line, resulting in a relatively low total and free brain/plasma ratio in mouse (<i>K</i><sub>p</sub> and estimated <i>K</i><sub>p(u,u)</sub> of 0.4 and 0.07, respectively). These observations are most likely p<i>K</i><sub>a</sub>-driven. More importantly, the improvement on hERG patch-clamp inhibition was most significant with the CF<sub>3</sub>-analogue <b>10</b>. Together with the better combination of brain penetration and significant in vivo efficacy, this prompted us to further explore the CF<sub>3</sub>-substituted morpholine series. An overview of the various CF<sub>3</sub>-substituted analogues and their primary in vitro activity is given in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activity and Metabolic Stability of 2-CF<sub>3</sub>–1,4-Oxazine Analogues<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0008.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The data represent the mean values of at least two independent experiments.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Compound <b>18</b> was tested as a racemate.</p></div></div><div></div></div><div class="NLM_p">Compounds <b>3</b> and <b>8</b>–<b>10</b> represent a set of standard variations of B-rings, widely used in the BACE1 inhibitor field.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> They all showed good enzymatic and cellular potency and minimal inhibition in the hERG patch-clamp assay (13–27% inhibition at 3 μM, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Compound <b>8</b> suffered from low metabolic stability and the same low bioavailability as its 2-fluoro-1,4-oxazine analogue <b>5</b> and was therefore not considered further. Analogues bearing substituents that extend deeper into the P3 pocket from the heteroaromatic B-ring, such as <b>26</b> and <b>27</b>, showed good potency although not improved over <b>3</b> and <b>8</b>–<b>10</b>. Polar substituents as the methoxyethoxy chain in <b>26</b> led to poor metabolic stability, whereas compounds with an increasingly lipophilic substituent suffered from a relative loss in cellular potency, as illustrated by going from <b>26</b> to <b>27</b> to <b>28</b>. Interestingly, while oxygen linked extensions were well tolerated in terms of enzymatic potency, nitrogen linked extensions (<b>29</b>–<b>31</b>) resulted in loss of activity, as best illustrated by comparison of the trifluoro ethoxy substituted <b>27</b> with the almost inactive nitrogen linked analogue <b>29</b>. To further investigate the influence of the P3 targeting moiety, the amide linker was omitted or replaced. Compounds bearing a bisaryl group, as exemplified by <b>18</b>, were significantly less potent, most likely due to a suboptimal filling of the P3 pocket. Replacement of the amide linker by a trans double bond (<b>19</b>), which should project the heteroaryl B-ring to a similar position as the amide linker, also resulted in a considerable loss in potency, possibly due to the loss of the H-bond interaction between the amide NH and Gly230 in BACE1. Indeed, the use of a NH linker, able to make H-bond interaction with Gly230, resulted in reasonably potent analogues as exemplified by <b>20</b>. The overall profile of <b>20</b> was however suboptimal, with high metabolic instability in human and mouse liver microsomes (36% and 100% metabolized, respectively, after 15 min incubation).</div><div class="NLM_p">To select the best compound for further progression, compounds <b>3</b>, <b>9</b>, and <b>10</b> were tested for their human hepatotoxicity potential, as drug induced liver injury led to the termination of the BACE1 inhibitor LY2886721 after phase 1 clinical trials.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The high content screening (HCS) multiparametric cytotoxicity assay is based on the simultaneous measurement of six key cell health indicators associated with nuclear morphology, plasma membrane integrity, mitochondrial function, and cell proliferation. It has been shown to be a sensitive test for the assessment of the hepatotoxic potential of chemical and pharmaceutical compounds.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In-house validation of the HCS cytotoxicity assay based on a EC<sub>20</sub> value of 30 μM for the lowest toxic concentration demonstrated a 67% sensitivity (33% false negatives) and a 100% specificity (no false positives) for the identification of severely hepatotoxic compounds. While 30 μM is considerably above the expected human efficacy and exposure levels, this cutoff value provides an empirically validated method to select the analogue with the lowest likelihood of hepatotoxicity. For <b>3</b>, <b>9</b>, and <b>10</b>, the lowest toxic concentrations were determined to be 31.5, 13.6, and 15.6 μM, respectively. This led to the selection of compound <b>3</b> as the preferred candidate to advance toward further profiling and in vivo testing.</div><div class="NLM_p">The metabolic stability was assessed more extensively across species and showed that compound <b>3</b> had acceptable stability in microsomes, as reflected by the in vitro predicted hepatic clearance, using the well-stirred model (human, rat, dog, mouse: 9.8, 32.3, 15.9, 60.6 mL/min/kg, respectively).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Also, low plasma protein binding was observed (<i>f</i><sub>u</sub> human, dog, mouse, rat: 36%, 26%, 23%, 26%), combined with a moderate free fraction in the brain (<i>f</i><sub>u,b</sub> rat: 3.0%). Compound <b>3</b> demonstrated a very weak inhibition potential toward cytochrome P450, reflected in IC<sub>50</sub> values >30 μM for all tested isoforms (1A2, 2C8, 2C9, 2C19, and 3A4) and no significant evidence of time dependent inhibition (TDI) against 3A4 up to 30 μM.</div><div class="NLM_p">In terms of enzymatic activity, <b>3</b> was 10-fold more potent toward BACE1 than BACE2, inhibition of which may lead to hair depigmentation.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> To further examine the selectivity profile of <b>3</b>, the compound was evaluated at Cerep for the inhibition of the aspartate proteases cathepsin D and E, as well as 50 other receptors, ion channels, or transporter targets. All tested targets showed less than 50% inhibition at a dose of 10 μM, except for κ (76%) and μ (91%) opiate receptors. The higher inhibition of the latter two did, however, not result in any functional effect.</div><div class="NLM_p">Compound <b>3</b> was tested in dose response in our dog PK/PD model. In single and repeated dose studies, doses up to 20 mg/kg were very well tolerated in dogs, with dose-related decreases in Aβ42 in CSF. The decreases lasted up to 49 h after dosing, corresponding to a half-life of 12 h for this compound.</div><div class="NLM_p">In <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the effect on Aβ42 levels in CSF and corresponding compound levels are shown after 1 and 6 days of treatment. The compound was well tolerated, without observations of changes in behavior and appearance. The dose-related decrease in CSF Aβ peptides was slightly more pronounced on day 6 compared to day 1. The data of all dog PK/PD experiments were used to determine the plasma EC<sub>50</sub> to lower Aβ42 in dog CSF for <b>3</b>. This resulted in a value of 105 ng/mL or 249 nM total plasma concentration.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This corresponds to a free concentration in dog of 65 nM, which is 3-fold above the in vitro IC<sub>50</sub> (22 nM).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Beagle dog plasma levels of <b>3</b> and effect on CSF Aβ42 levels on day 1 and 6 after repeated oral dosing (fasted state, once daily dosing). Avg + SEM, <i>n</i> = 6/dose group (MS: MesoScale).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pharmacokinetic profile and oral bioavailability of <b>3</b> were investigated in mouse, rat, and dog following intravenous and oral administration (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters for <b>3</b> (single dose; <i>n</i> = 3)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">mouse</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">human<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg/kg) iv/po</td><td class="colsep0 rowsep0" align="left">2.5/10</td><td class="colsep0 rowsep0" align="left">2.5/10</td><td class="colsep0 rowsep0" align="left">1/10</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/min/kg) iv</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">7.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LM CL (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">60.6</td><td class="colsep0 rowsep0" align="left">32.3</td><td class="colsep0 rowsep0" align="left">15.9</td><td class="colsep0 rowsep0" align="left">9.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><i>f<sub>u</sub></i>, plasma (%)</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vd<sub>ss</sub> (L/kg) iv</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">7.6</td><td class="colsep0 rowsep0" align="left">11.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LBF (%) iv</td><td class="colsep0 rowsep0" align="left">∼50</td><td class="colsep0 rowsep0" align="left">∼67</td><td class="colsep0 rowsep0" align="left">∼25</td><td class="colsep0 rowsep0" align="left">∼25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h) iv</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (nM) po</td><td class="colsep0 rowsep0" align="left">333</td><td class="colsep0 rowsep0" align="left">160</td><td class="colsep0 rowsep0" align="left">1092</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h) po</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub> (ng·h/mL) po</td><td class="colsep0 rowsep0" align="left">1334</td><td class="colsep0 rowsep0" align="left">1220</td><td class="colsep0 rowsep0" align="left">15433</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i>% po</td><td class="colsep0 rowsep0" align="left">45</td><td class="colsep0 rowsep0" align="left">36</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">54</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">In vivo Human PK data are predicted values derived by allometric scaling.</p></div></div></div><div class="NLM_p">The clearance data (CL) are in line with the in vitro predictions: while the systemic clearance in mouse and rat was moderate to moderately high, it was low in dog. The volume of distribution (Vd<sub>ss</sub>), on the other hand, was large across the species, indicating there is significant tissue distribution, which results in a half-life (<i>T</i><sub>1/2</sub>) of 12 h for the dog. Following oral dosing, the compound was rapidly absorbed in mouse but slowly in rat and dog. Given the high systemic exposure (<i>C</i><sub>max</sub> and AUC), the bioavailability was acceptable across species and the balance between clearance (% liver blood flow (LBF)) and bioavailability indicated that absorption was complete.</div><div class="NLM_p">These PK parameters were used for interspecies allometric scaling, resulting in a predicted low clearance in human (25% LBF), with a large volume of distribution (11.5 L/kg) and a long half-life (25 h). Assuming an estimated bioavailability of 54% in human (based on the average bioavailability in preclinical species), a once daily dose of 150 mg was predicted to maintain plasma concentrations of 100 ng/mL, required for achieving a sustained reduction of at least 50% of CSF Aβ levels and building a maximum concentration of 175 ng/mL at this repeated dose.</div><div class="NLM_p">In the hERG potassium ion channel binding assay, compound <b>3</b> showed less than 50% binding up to the highest dose (10 μM) tested (IC<sub>50</sub> > 10 μM). This correlated with a relatively low functional hERG inhibition in the hERG patch-clamp assay (22% inhibition at 3 μM). To assess the cardiovascular safety more profoundly, the compound was subjected to a pharmacology study in anesthetized female guinea pigs. In this model, prolongation of the QT interval was measured after administration of <b>3</b> by iv infusion in pentobarbital anesthetized animals (cumulatively dosed up to 10 mg/kg iv). At the top dose, at an exposure of 11500 ng/mL, a slight QTcB prolongation was observed (+9% versus +7% with vehicle). With a free plasma concentration in guinea pig determined at 37%, this corresponds to a free concentration of 10.1 μM, confirming the lack of significant findings in the hERG in vitro assays below 10 μM. No relevant effect on QTcB was observed at an exposure of 5235 ng/mL (4.60 μM free), hence the reduced hERG inhibition was translated into an improved no observed adverse effect level (NOAEL). On the basis of these data, <b>3</b> has a potential to prolong the QTc interval only at exposures over 65-fold the predicted human <i>C</i><sub>max</sub> (175 ng/mL, 0.15 μM free) or a safety margin for QTc prolongation of 30-fold when using total concentrations and 31-fold when using free concentrations. The key data and margins are tabulated in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> together with the available data for <b>2</b>. To assess the improvement in CV safety profile of <b>3</b> over <b>2</b>, we compared safety margins based on dog efficacy levels because human PK and dose prediction have not been performed for <b>2</b>. Typically, a safety margin of minimally 30-fold is considered optimal. This margin is met for <b>3</b>, irrespective of the method of calculation. On the basis of the dog EC<sub>50</sub> data, a 6–8-fold margin improvement has been achieved for <b>3</b> over <b>2</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Comparison of Cardiovascular Safety Data and Margins for <b>2</b> and <b>3</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>2</b></th><th class="colsep0 rowsep0" align="center"><b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BACE1 IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">22.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hAβ42 cell IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left">6.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG binding IC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">8.3 μM</td><td class="colsep0 rowsep0" align="left">>10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG PC (% inh. @ 3 μM)</td><td class="colsep0 rowsep0" align="left">56</td><td class="colsep0 rowsep0" align="left">22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f<sub>u</sub></i> plasma dog, guinea pig, human (%)</td><td class="colsep0 rowsep0" align="left">42, 41, 43</td><td class="colsep0 rowsep0" align="left">26, 37, 36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LOAEL for QTcB prolongation</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total conc (ng/mL)</td><td class="colsep0 rowsep0" align="left">475</td><td class="colsep0 rowsep0" align="left">11500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">free conc (μM)</td><td class="colsep0 rowsep0" align="left">0.55</td><td class="colsep0 rowsep0" align="left">10.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NOAEL for QTcB prolongation</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total conc (ng/mL)</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">5235</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">free conc (μM)</td><td class="colsep0 rowsep0" align="left">0.20</td><td class="colsep0 rowsep0" align="left">4.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human <i>C</i><sub>max</sub> (predicted for 50% Aβ reduction in CSF)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total conc (ng/mL)</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">175</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">free conc (μM)</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> in dog (50% Aβ reduction in CSF)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total conc (ng/mL)</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">free conc (μM)</td><td class="colsep0 rowsep0" align="left">0.023</td><td class="colsep0 rowsep0" align="left">0.065</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">safety margin: NOAEL vs human <i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total conc</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">30-fold</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">free conc</td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="left">31-fold</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">safety margin: NOAEL vs dog EC<sub>50</sub></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total conc</td><td class="colsep0 rowsep0" align="left">8.5-fold</td><td class="colsep0 rowsep0" align="left">50-fold</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">free conc</td><td class="colsep0 rowsep0" align="left">8.7-fold</td><td class="colsep0 rowsep0" align="left">71-fold</td></tr></tbody></table></div></div><div class="NLM_p">In terms of mutagenic potential, <b>3</b>, as well as its main metabolites, was clean in vitro both in nonmammalian cell systems (AMES II)<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> as in mammalian cell systems (micronucleus test, MNT). Also, no reactive metabolite formation was observed using glutathione- or CN-trapping assays. The aniline <b>16</b>, a major metabolite, was tested separately in both AMES II and MNT and also found to be clean.</div><div class="NLM_p">The tissue distribution of <b>3</b> was investigated in male Sprague–Dawley rat following po administration of a nominal dose of 10 mg/kg. Concentrations were particularly high in kidney, liver, and lung compared to plasma, with ratios of 19, 31, and 169, respectively. Given these relatively high tissue distribution levels in rat, <b>3</b> was evaluated for its potential to induce phospholipidosis in human THP-1 monocytes by using a fluorescence assay.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Concentrations up to 200 μM were tested, where the compound induced a 2-fold increase in fluorescence at 21 μM, indicating a weak potential for phospholipidosis.</div><div class="NLM_p">Compound <b>3</b> was subsequently progressed into 1-month repeated dose oral, good laboratory practices (GLP) toxicity studies in rat and dog with a 1-month recovery period to investigate the reversibility of any possible toxicological effect. In rat, the compound was well tolerated at doses of 25 and 75 mg/kg/day. At a dose of 75 mg/kg/day, an increase in cholesterol and a minimal to slight increase in foamy macrophages in the lung, suggestive of phospholipidosis, were noted in female rats. At 225 mg/kg/day, histological changes indicative for phospholipidosis were more pronounced and present in various tissues, including kidney and lung, in addition to transient effects on body weight, food consumption, and clinical pathology. The 75 mg/kg/day was considered to be the no observed adverse effect level (NOAEL) with exposures for male and female rats indicated in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. With a p<i>K</i><sub>a</sub> lower than 8 and a cLogP lower than 2, <b>3</b> does not have the characteristics of a typical phospholipidosis inducer,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> as confirmed by the only weak potential to induce phospholipidosis in the in vitro assay. An explanation for the phospholipidosis observed in the toxicology studies probably lies in the tissue distribution of the compound, with high tissue/plasma ratios especially in those tissues where indications of phospholipidosis were observed. The phospholipidosis was found to be reversible during a 1-month recovery period following the 1-month treatment. In addition, even in the high dose group, no signals of tissue damage of toxicity were observed which could be linked to the phospholipidosis. Therefore, phospholipidosis was not considered as a showstopper to move into clinical trials.</div><div class="NLM_p">In dog, <b>3</b> was dosed orally at 20, 70, and 250 mg/kg/day. During the first week of dosing, the dogs were fed immediately after dosing. At 70 and 250 mg/kg/day, this resulted in central nervous system (CNS) symptoms (ataxia, decreased general activity, and/or tremors). From the fifth dose onward, dogs were fasted up to 4 h after dosing, and this resulted in lower exposures and consequently in the disappearance of CNS symptoms. A minimal decrease in red blood cell parameters was seen in males dosed at 250 mg/kg/day. There were no relevant changes at the end of the 1-month recovery period. On the basis of these findings, the NOAEL for <b>3</b> in dog was 70 mg/kg/day with the exposures given in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. No depigmentation was observed in either the rat or dog toxicity studies. The 10-fold selectivity of BACE1 over BACE2 may be advantageous here, but a longer treatment period will be required to exclude depigmentation upon chronic BACE1 and BACE2 inhibition.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. NOAEL After a 1-Month Repeated Dose GLP Toxicity Study in Rat and Dog</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">male</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">female</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg/day)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC 0–24 h (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC 0–24 h (ng·h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">1490</td><td class="colsep0 rowsep0" align="char" char=".">13663</td><td class="colsep0 rowsep0" align="char" char=".">2723</td><td class="colsep0 rowsep0" align="char" char=".">38846</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">1973</td><td class="colsep0 rowsep0" align="char" char=".">26319</td><td class="colsep0 rowsep0" align="char" char=".">2083</td><td class="colsep0 rowsep0" align="char" char=".">23066</td></tr></tbody></table></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37723" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37723" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Replacement of the 2-fluoro substituent in <b>2</b> with a trifluoromethyl group resulted in improvement on hERG inhibition. While 2-fluoro-1,4-oxazine amidine <b>2</b> was more potent in vivo (EC<sub>50</sub> 20 ng/mL vs 105 ng/mL for <b>3</b>), the CF<sub>3</sub>-oxazine <b>3</b> has an improved cardiovascular profile, with a sufficient safety margin of at least 30-fold of the NOAEL over the human predicted dose. Also, concerns around the potential chemical instability of the anomeric-like fluorine in <b>2</b> were mitigated. Compound <b>3</b> was considered sufficiently safe in toxicity assessment studies and is now positioned to move into clinical trials.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemistry</h3><div class="NLM_p">All reactions were carried out by employing standard chemical techniques under inert atmosphere. Solvents used for extraction, washing, and chromatography were HPLC grade. Unless otherwise noted, all reagents were purchased from Sigma-Aldrich or Acros Organics and were used without further purification. All final compounds were characterized by <sup>1</sup>H NMR and LC/MS. <sup>1</sup>H nuclear magnetic resonance spectra were recorded on Bruker spectrometers: 360 MHz, DPX-400 MHz, and AV-500 MHz. For the <sup>1</sup>H spectra, all chemical shifts are reported in part per million (δ) units and are relative to the residual signal at 7.26 and 2.50 ppm for CDCl<sub>3</sub> and DMSO, respectively. <sup>13</sup>C chemical shifts are reported as δ values in ppm relative to the residual solvent peak (CDCl<sub>3</sub> = 77.16). All final compounds were confirmed to be >95% pure via HPLC methods. All the LC/MS analyses were performed using an Agilent G1956A LC/MS quadrupole coupled to an Agilent 1100 series liquid chromatography (LC) system consisting of a binary pump with degasser, autosampler, thermostated column compartment, and diode array detector. The mass spectrometer (MS) was operated with an atmospheric pressure electrospray ionization (API-ES) source in positive ion mode. The capillary voltage was set to 3000 V and the fragmentor voltage to 70 V, and the quadrupole temperature was maintained at 100 °C. The drying gas flow and temperature values were 12.0 L/min and 350 °C, respectively. Nitrogen was used as the nebulizer gas at a pressure of 35 psig. Data acquisition was performed with Agilent Chemstation software. Analyses were carried out on a YMC pack ODS-AQ C18 column (50 mm long × 4.6 mm I.D.; 3 μm particle size) at 35 °C, with a flow rate of 2.6 mL/min. A gradient elution was performed from 95% (water + 0.1% formic acid)/5% acetonitrile to 5% (water + 0.1% formic acid)/95% acetonitrile in 4.8 min; the resulting composition was held for 1.0 min; from 5% (water + 0.1% formic acid)/95% acetonitrile to 95% (water + 0.1% formic acid)/5% acetonitrile in 0.2 min. The standard injection volume was 2 μL. Acquisition ranges were set to 190–400 nm for the UV-PDA detector and 100–1400 <i>m</i>/<i>z</i> for the MS detector. Optical rotations measurements were carried out on a 341 PerkinElmer polarimeter in the indicated solvents. Melting points were determined with a DSC823e (Mettler-Toledo) and were measured with a temperature gradient of 30 °C/min. The reported values are peak values. The synthesis and characterization of intermediates <b>11</b>–<b>16</b> and compounds <b>1</b>, <b>2</b>, <b>6</b>, <b>7</b>, and <b>10</b> have been described before.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The following section comprises the synthetic procedures and analytical data for all other final compounds reported in this manuscript.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> <i>N</i>-{3-[(2<i>R</i>,3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide (<b>3</b>)</h4><div class="NLM_p last">5-Cyano-2-pyridinecarboxylic acid (1.56 g, 10.5 mmol) and 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl morpholinium chloride (3.72 g, 12.6 mmol) were dissolved in MeOH (400 mL) at rt. After stirring for 5 min at rt, the mixture was cooled on an ice bath and a solution of aniline <b>16</b><a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (3.40 g, 10.5 mmol) in MeOH (10 mL) was added. The mixture was stirred at 0 °C for 6 h, then stirred at rt overnight. The mixture was partitioned between a satd aq NaHCO<sub>3</sub> solution and DCM. The organic layer was dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. The crude product was purified by flash column chromatography (silica; 7 N solution of ammonia in MeOH/DCM 0/100 to 5/95). The desired fractions were collected and the solvents evaporated in vacuo and subsequently triturated with diisopropylether/2-propanol, filtered, and dried in vacuo to yield <b>3</b> as a white solid (1.83 g, 41% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ (ppm) 1.56 (s, 3H), 4.10 (d, <i>J</i> = 15.9 Hz, 1H), 4.23 (d, <i>J</i> = 15.9 Hz, 1H), 4.54 (q, <i>J</i> = 8.1 Hz, 1H), 7.13 (dd, <i>J</i> = 12.0, 8.8 Hz, 1H), 5.86 (s, 2H), 7.86–7.79 (m, 1H), 8.18 (dd, <i>J</i> = 7.2, 2.8 Hz, 1H), 8.28 (dd, <i>J</i> = 8.2, 0.8 Hz, 1H), 8.58 (dd, <i>J</i> = 8.2, 2.0 Hz, 1H), 9.20 (dd, <i>J</i> = 2.0, 0.8 Hz, 1H), 10.77 (s, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ (ppm) 28.6 (d, <i>J</i><sub>C–F</sub> = 3.8 Hz), 55.2 (d, <i>J</i><sub>C–F</sub> = 3.6 Hz), 58.5, 72.5 (dq, <i>J</i><sub>C–F</sub> = 27.3, 5.6 Hz), 112.4, 116.0, 116.2 (d, <i>J</i><sub>C–F</sub> = 25.1 Hz), 120.4 (d, <i>J</i><sub>C–F</sub> = 8.7 Hz), 120.9 (d, <i>J</i><sub>C–F</sub> = 4.7 Hz), 122.3, 124.1 (q, <i>J</i><sub>C–F</sub> = 286.1 Hz), 130.8 (d, <i>J</i><sub>C–F</sub> = 14.0 Hz), 133.2 (d, <i>J</i><sub>C–F</sub> = 2.3 Hz), 141.3, 150.7, 152.4, 154.6, 157.7 (d, <i>J</i><sub>C–F</sub> = 242.7 Hz), 159.9. [α]<sup>20</sup><sub>D</sub> = −31.6 (<i>c</i> = 0.14 in MeOH); melting point 240 °C. LRMS (ESI) <i>m</i>/<i>z</i>: [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>16</sub>F<sub>4</sub>N<sub>5</sub>O<sub>2</sub> 422.1, found 422.1. Anal. Calcd for C<sub>19</sub>H<sub>15</sub>F<sub>4</sub>N<sub>5</sub>O<sub>2</sub>: C, 54.16%; H, 3.59%; N, 16.62%. Found: C, 54.23%; H, 3.36%; N, 16.54%.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> <i>N</i>-{3-[(2<i>R</i>,3<i>R</i>)-5-Amino-2-fluoro-3-methyl-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-cyano-3-fluoropyridine-2-carboxamide (<b>4</b>)</h4><div class="NLM_p last">Starting from (5<i>R</i>,6<i>R</i>)-5-(5-amino-2-fluorophenyl)-6-fluoro-5-methyl-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (73 mg, 0.3 mmol) and 5-cyano-3-fluoropyridine-2-carboxylic acid (50 mg, 0.3 mmol), and following the same procedure as for <b>3</b>, the corresponding <b>4</b> was obtained (52 mg, 44% yield). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ 1.65 (s, 3 H) 4.04 (d, <i>J</i> = 15.4 Hz, 1H) 4.27 (d, <i>J</i> = 15.7 Hz, 1H) 6.04 (d, <i>J</i> = 52.7 Hz, 1H) 7.09 (dd, <i>J</i> = 11.3, 8.8 Hz, 1H) 7.46 (dd, <i>J</i> = 6.8, 2.7 Hz, 1H) 7.85–7.96 (m, 2H) 8.70 (d, <i>J</i> = 1.8 Hz, 1H) 9.53–9.71 (br s, 1H). LC-MS <i>m</i>/<i>z</i> 390 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-{3-[(2<i>R</i>,3<i>R</i>)-5-Amino-2-fluoro-3-methyl-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-3-chloro-5-cyanopyridine-2-carboxamide (<b>5</b>)</h4><div class="NLM_p last">Starting from (5<i>R</i>,6<i>R</i>)-5-(5-amino-2-fluorophenyl)-6-fluoro-5-methyl-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (0.10 g, 0.42 mmol) and 3-chloro-5-cyanopyridine-2-carboxylic acid (83 mg, 0.46 mmol), and following the same procedure as for <b>3</b>, the corresponding <b>5</b> was obtained as a solid after trituration with heptane (50 mg, 30% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 1.65 (s, 3H), 4.04 (d, <i>J</i> = 15.6 Hz, 1H), 4.27 (d, <i>J</i> = 15.6 Hz, 1H), 6.05 (d, <i>J</i> = 52.0 Hz, 1H), 7.10 (dd, <i>J</i> = 11.3, 9.0 Hz, 1H), 7.40 (dd, <i>J</i> = 6.8, 2.5 Hz, 1H), 7.94 (dt, <i>J</i> = 8.5, 3.3 Hz, 1H), 8.13–8.19 (m, 1H), 8.74 (d, <i>J</i> = 1.2 Hz, 1H), 9.66 (br s, 1H). LC-MS <i>m</i>/<i>z</i> 406 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = +75.6 (<i>c</i> = 0.52 in DMF); mp = 125.5 °C.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-{3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-3-chloro-5-cyanopyridine-2-carboxamide (<b>8</b>)</h4><div class="NLM_p last">Starting from aniline <b>16</b> (0.16 g, 0.47 mmol) and 3-chloro-5-cyanopyridine-2-carboxylic acid (85 mg, 0.47 mmol), following the same procedure as for <b>3</b>, the corresponding <b>8</b> was obtained (85 mg, 40% yield). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ ppm 1.68 (s, 3H), 1.71–1.95 (m, 2H), 4.24 (s, 2H), 4.66 (q, <i>J</i> = 8.4 Hz, 1H), 7.07 (dd, <i>J</i> = 11.5, 9.0 Hz, 1H), 7.87 (dd, <i>J</i> = 6.6, 2.9 Hz, 1H), 8.06 (ddd, <i>J</i> = 8.8, 4.0, 2.9 Hz, 1H), 8.17 (d, <i>J</i> = 1.8 Hz, 1H), 8.73 (d, <i>J</i> = 1.5 Hz, 1H), 9.76 (s, 1H). LC-MS <i>m</i>/<i>z</i> 456 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −33.8 (<i>c</i> = 0.59 in DMF).</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>N</i>-{3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-chloropyridine-2-carboxamide (<b>9</b>)</h4><div class="NLM_p last">Starting from aniline <b>16</b> (0.25 g, 0.86 mmol) and 5-chloropyridine-2-carboxylic acid (135 mg, 0.86 mmol), following the same procedure as for <b>3</b>, the corresponding <b>9</b> was obtained as a solid after trituration with diisopropylether (230 mg, 62% yield). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>) δ 1.69 (s, 3H) 4.19–4.31 (m, 2H) 4.28–4.54 (m, 2H) 4.66 (q, <i>J</i> = 8.1 Hz, 1H) 7.06 (dd, <i>J</i> = 11.7, 8.8 Hz, 1H) 7.88 (dd, <i>J</i> = 8.4, 2.6 Hz, 1H) 7.91 (dd, <i>J</i> = 6.8, 2.7 Hz, 1H) 7.99–8.08 (m, 1H) 8.25 (d, <i>J</i> = 8.4 Hz, 1H) 8.56 (d, <i>J</i> = 2.2 Hz, 1H) 9.88 (br. s, 1H). LC-MS <i>m</i>/<i>z</i> 431 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −36.8 (<i>c</i> = 0.23 in MeOH); mp = 218.3 °C.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (5<i>RS</i>,6<i>RS</i>)-5-(2-Fluoro-5-(pyrimidin-5-yl)phenyl)-5-methyl-6-(trifluoromethyl)-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine (<b>18</b>)</h4><div class="NLM_p last">Racemic bromide <b>15</b> (100 mg, 0.28 mmol), 5-pyrimidinylboronic acid (70 mg, 0.56 mmol), and tetrakis(triphenylphosphine)palladium (33 mg, 0.028 mmol) were dissolved in a mixture of saturated aq NaHCO<sub>3</sub> solution (5 mL) and 1,4-dioxane (4 mL). The mixture was flushed with nitrogen and then heated at 80 °C for 2 h. The mixture was allowed to come to rt, water was added, and the mixture was extracted with DCM. The organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. The crude product was purified by flash column chromatography (silica; 7 N solution of ammonia in MeOH/DCM 0/100 to 10/90). The desired fractions were collected and the solvents evaporated in vacuo to give <b>18</b> (85 mg, 85% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.59 (s, 3H), 4.06–4.29 (m, 2H), 4.65 (q, <i>J</i> = 8.5 Hz, 1H), 5.95 (br s, 2H), 7.32 (dd, <i>J</i> = 12.0, 8.5 Hz, 1H), 7.78 (ddd, <i>J</i> = 8.4, 4.5, 2.6 Hz, 1H), 8.21 (dd, <i>J</i> = 7.3, 2.5 Hz, 1H), 9.06 (s, 2H), 9.20 (s, 1H). LC-MS <i>m</i>/<i>z</i> 355 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 6-((<i>E</i>)-3-((2<i>R</i>,3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorostyryl)nicotinonitrile (<b>19</b>)</h4><div class="NLM_p last">Bromide <b>15</b> (123 mg, 0.35 mmol), (<i>E</i>)-(2-(5-cyanopyridin-2-yl)vinyl)boronic acid pinacol ester (89 mg, 0.35 mmol), and tetrakis(triphenylphosphine)palladium (40 mg, 0.035 mmol) were dissolved in a mixture of saturated aq NaHCO<sub>3</sub> solution (0.4 mL) and 1,4-dioxane (4.9 mL). The mixture was flushed with nitrogen and then heated at 140 °C for 30 min under microwave irradiation. The mixture was allowed to come to rt, water was added, and the mixture was extracted with DCM. The organic layer was separated, washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated in vacuo. The crude product was purified by flash column chromatography (silica; 7 N solution of ammonia in MeOH/DCM 0/100 to 4/96). The desired fractions were collected and the solvents evaporated in vacuo to give <b>19</b> (36 mg, 26% yield). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ ppm 1.69 (d, <i>J</i> = 0.7 Hz, 3H), 4.24 (s, 2H), 4.64 (q, <i>J</i> = 8.4 Hz, 1H), 7.05 (dd, <i>J</i> = 11.7, 8.4 Hz, 1H), 7.12 (d, <i>J</i> = 16.1 Hz, 1H), 7.42 (d, <i>J</i> = 8.4 Hz, 1H), 7.51 (ddd, <i>J</i> = 8.4, 4.8, 2.6 Hz, 1H), 7.78 (d, <i>J</i> = 16.1 Hz, 1H), 7.88 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 8.15 (dd, <i>J</i> = 7.7, 2.2 Hz, 1H), 8.82 (d, <i>J</i> = 2.2 Hz, 1H). LC-MS <i>m</i>/<i>z</i> 405 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 2-((3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-amino))nicotinonitrile (<b>20</b>)</h4><div class="NLM_p last">Aniline <b>16</b> (0.358 g, 1.23 mmol) was dissolved in 1,4-dioxane (15 mL). 2-Bromo-3-cyanopyridine (191 mg, 1.05 mmol), cesium carbonate (0.80 g, 2.46 mmol), and 1,1′-bis(diphenylphosphino)ferrocene (103 mg, 0.18 mmol) were added and the mixture stirred under argon atmosphere for a few minutes. Tris(dibenzylidene-acetone)dipalladium(0) (56 mg, 0.062 mmol) was then added. The reaction tube was sealed, and the mixture was stirred at 160 °C for 1 h under microwave irradiation. After cooling, the reaction mixture was diluted with DCM and filtered over dicalite. The filtrate was concentrated in vacuo. The crude product was purified by flash column chromatography (silica; 7 N solution of ammonia in MeOH/DCM 0/100 to 5/95). The desired fractions were collected and concentrated. This crude was further purified by preparative SFC on (Chiralpak Diacel AS 20 mm × 250 mm). Mobile phase (CO<sub>2</sub>, MeOH with 0.2% iPrNH<sub>2</sub>) to yield <b>20</b> (0.052 g, 11% yield). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ ppm 1.67 (s, 3H) 4.14–4.34 (m, 4H) 4.65 (d, <i>J</i> = 8.42 Hz, 1H) 6.78 (dd, <i>J</i> = 7.50, 4.94 Hz, 1H) 6.98–7.08 (m, 2H) 7.71 (dd, <i>J</i> = 6.59, 2.93 Hz, 1H) 7.78 (dd, <i>J</i> = 7.68, 1.83 Hz, 1H) 7.94 (ddd, <i>J</i> = 8.78, 4.03, 2.93 Hz, 1H) 8.37 (dd, <i>J</i> = 5.12, 1.83 Hz, 1H). LC-MS <i>m</i>/<i>z</i> 394 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −21.3 (<i>c</i> = 0.36 in DMF).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (5<i>R</i>)-5-(5-Bromo-2-fluorophenyl)-6-(difluoromethylene)-5-methylmorpholin-3-one (<b>21</b>)</h4><div class="NLM_p last">(5<i>R</i>)-5-(5-Bromo-2-fluorophenyl)-6-chloro-5-methyl-6-(trifluoromethyl)morpholin-3-one (<b>13</b>)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> (7 g, 17.9 mmol) and zinc copper couple (8.55 g, 66.3 mmol) were stirred in acetic acid (420 mL) at rt for 16 h. The reaction mixture was filtered, washed with DCM, and concentrated in vacuo. Ammonium hydroxide solution (28% in water) and DCM were added and the mixture was stirred at rt for 1 h. The organic layer was separated, and the aqueous layer was extracted with DCM. The combined organic layers were dried (MgSO<sub>4</sub>), filtered, and evaporated in vacuo to yield <b>21</b> (6 g, 99% yield) as a white powder. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 1.73 (d, <i>J</i> = 5.1 Hz, 3H), 4.27–4.44 (m, 2H), 7.26 (dd, <i>J</i> = 11.7, 8.8 Hz, 1H), 7.55 (dd, <i>J</i> = 7.3, 2.6 Hz, 1H), 7.60–7.67 (m, 1H), 9.07 (s, 1H). LC-MS <i>m</i>/<i>z</i> 337 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (5<i>R</i>)-5-(5-Bromo-2-fluorophenyl)-6-(difluoromethylene)-5-methyl-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine (<b>22</b>)</h4><div class="NLM_p last">P<sub>2</sub>S<sub>5</sub> (5.95 g, 26.8 mmol) was added to a solution of <b>21</b> (6 g, 17.9 mmol) in THF (145 mL) at rt. The reaction mixture was stirred at 70 °C for 90 min. Then the mixture was cooled to rt, filtered off, and the organic solvent evaporated in vacuo to yield crude (5<i>R</i>)-5-(5-bromo-2-fluorophenyl)-6-(difluoromethylene)-5-methylmorpholin-3-thione (5.9 g). This was dissolved in 7N ammonia in MeOH (390 mL), and the reaction mixture was stirred at 80 °C for 2 h. The solvent was evaporated and the crude product purified by column chromatography (silica; 7 N solution of ammonia in MeOH/DCM 0/100 to 5/95). The desired fractions were collected and concentrated in vacuo to yield <b>22</b> (4.04 g, 72% yield). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ ppm 1.72 (d, <i>J</i> = 4.0 Hz, 3H), 4.29 (s, 2H), 6.90 (dd, <i>J</i> = 11.3, 8.8 Hz, 1H), 7.35 (ddd, <i>J</i> = 8.6, 4.2, 2.6 Hz, 1H), 7.53 (dd, <i>J</i> = 7.3, 2.6 Hz, 1H). LC-MS <i>m</i>/<i>z</i> 336 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (5<i>R</i>)-5-(5-Amino-2-fluorophenyl)-6-(difluoromethylene)-5-methyl-5,6-dihydro-2<i>H</i>-1,4-oxazin-3-amine (<b>23</b>)</h4><div class="NLM_p last">Compound <b>22</b> (3.6 g, 10.7 mmol) was mixed with NaN<sub>3</sub> (1.75 g, 26.9 mmol), CuI (2.56 g, 13.4 mmol), and Na<sub>2</sub>CO<sub>3</sub> (2.28 g, 21.5 mmol) in DMSO (153 mL), and the reaction mixture was degassed. After that, <i>N</i>,<i>N</i>′-dimethylethylenediamine (2 mL, 18.8 mmol) was added and the mixture was heated at 110 °C until completion of the reaction, about 3 h. The reaction mixture was concentrated in vacuo. 7N ammonia in MeOH was added, and the mixture was stirred overnight. The precipitate formed was filtered off, and the filtrate was concentrated in vacuo. The crude product was purified by column chromatography (silica; eluent, 7 M solution of ammonia in MeOH/DCM 0/100 to 30/70). The desired fractions were collected and concentrated in vacuo to yield <b>23</b> (1.52 g, 52% yield). <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 1.53 (d, <i>J</i> = 4.4 Hz, 2H), 4.07–4.29 (m, 1H), 4.90 (s, 1H), 5.90 (s, 1H), 6.34–6.45 (m, 1H), 6.60 (dd, <i>J</i> = 7.0, 2.9 Hz, 1H), 6.73 (dd, <i>J</i> = 11.7, 8.8 Hz, 1H). LC-MS <i>m</i>/<i>z</i> 272 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-{3-(3<i>R</i>)-(5-Amino-2-(difluoromethylene)-3-methyl-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl)-4-fluorophenyl}-5-methoxypyrazine-2-carboxamide (<b>24</b>)</h4><div class="NLM_p last">5-Methoxypyrazine-2-carboxylic acid (0.22 g, 1.42 mmol) was dissolved in MeOH (30 mL), and DMTMM (0.46 g, 1.55 mmol) was added. After stirring the mixture for 5 min, a solution of aniline <b>23</b> (0.35 g, 1.29 mmol) in MeOH (20 mL) was added at 0 °C, and the mixture was stirred for 16 h at rt. The solvent was evaporated in vacuo. The crude material was purified by flash column chromatography (silica; eluent, 7 M solution of ammonia in MeOH/DCM 0/100 to 5/95). The desired fractions were collected and concentrated in vacuo. The residue was suspended from diisopropylether/heptanes, filtered, and dried under high vacuum to yield <b>24</b> (0.27 g, 51% yield) as a white solid. <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 1.62 (d, <i>J</i> = 3.7 Hz, 2H), 4.02 (s, 2H), 4.24 (d, <i>J</i> = 13.2 Hz, 2H), 5.98 (br s, 2H), 7.04–7.16 (m, 1H), 7.75–7.84 (m, 1H), 7.96 (dd, <i>J</i> = 7.3, 2.6 Hz, 1H), 8.41 (d, <i>J</i> = 1.1 Hz, 1H), 8.89 (d, <i>J</i> = 1.1 Hz, 1H), 10.57 (s, 1H). LC-MS <i>m</i>/<i>z</i> 408 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = +156.8 (<i>c</i> = 0.36 in DMF).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-{3-[(2<i>R</i>,3<i>R</i>)-5-Amino-2-(difluoromethyl)-3-methyl-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-methoxypyrazine-2-carboxamide (<b>25</b>)</h4><div class="NLM_p last">Compound <b>24</b> (0.154 g, 0.378 mmol) was dissolved in EtOAc (5 mL), and palladium on carbon (10%) (0.04 g, 0.038 mmol) and thiophene (0.4% solution in THF, 0.5 mL, 0.026 mmol) were added. The mixture was hydrogenated at rt and atmospheric pressure for 16 h. The catalyst was filtered off and the solvents evaporated in vacuo. The crude product was purified by flash column chromatography (silica; eluent, 7 M solution of ammonia in MeOH/DCM 0/100 to 2/98). The desired fractions were collected and concentrated in vacuo. The residue was suspended from diisopropylether, filtered, and dried under high vacuum to yield <b>25</b> (67 mg, 43% yield). <sup>1</sup>H NMR (360 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 1.52 (s, 3H), 3.93–4.01 (m, 1H), 4.02 (s, 3H), 4.10 (d, <i>J</i> = 15.9 Hz, 1H), 4.15 (d, <i>J</i> = 15.9 Hz, 1H), 5.64 (td, <i>J</i> = 54.0, 4.4 Hz, 1H), 5.80 (br s, 2H), 7.11 (dd, <i>J</i> = 12.1, 8.8 Hz, 1H), 7.80 (ddd, <i>J</i> = 8.8, 4.1, 2.7 Hz, 1H), 8.04 (dd, <i>J</i> = 7.3, 2.8 Hz, 1H), 8.42 (d, <i>J</i> = 1.3 Hz, 1H), 8.88 (d, <i>J</i> = 1.3 Hz, 1H), 10.44 (s, 1H). LC-MS <i>m</i>/<i>z</i> 410 [M + H]<sup>+</sup>; mp = 227.3 °C.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-{3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-(2-methoxyethoxy)pyrazine-2-carboxamide (<b>26</b>)</h4><div class="NLM_p last">Starting from aniline <b>16</b> (0.25 g, 0.86 mmol) and 5-(2-methoxyethoxy)pyrazine-2-carboxylic acid (CAS 710322-69-3; 135 mg, 0.86 mmol), following the same procedure as for <b>3</b>, the corresponding <b>26</b> was obtained as a solid after trituration with diisopropylether (230 mg, 62% yield). <sup>1</sup>H NMR (360 MHz, CDCl<sub>3</sub>): δ ppm 1.68 (s, 3H), 3.46 (s, 3H), 3.76–3.83 (m, 2H), 4.23 (s, 2H), 4.34 (br s, 2H), 4.57–4.69 (m, 3H), 7.05 (dd, <i>J</i> = 1 1.5, 9.0 Hz, 1H), 7.89 (dd, <i>J</i> = 6.8, 2.7 Hz, 1H), 8.03 (dt, <i>J</i> = 8.8, 3.5 Hz, 1H), 8.21 (s, 1H), 8.99 (d, <i>J</i> = 0.7 Hz, 1H), 9.55 (s, 1H). LC-MS <i>m</i>/<i>z</i> 472 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −17.5 (<i>c</i> = 0.32 in DMF).</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-{3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-(2,2,2-trifluoroethoxy)pyrazine-2-carboxamide (<b>27</b>)</h4><div class="NLM_p last">Starting from aniline <b>16</b> (0.10 g, 0.34 mmol) and 5-(2,2,2-trifluoroethoxy)-pyrazine-2-carboxylic acid (CAS 1174323-36-4; 76 mg, 0.34 mmol), following the same procedure as for <b>3</b>, the corresponding <b>27</b> was obtained as a solid (20 mg, 12% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 1.68 (s, 3 H), 4.19–4.27 (m, 2 H), 4.30 (br s, 2 H), 4.65 (q, <i>J</i> = 8.1 Hz, 1 H), 4.86 (q, <i>J</i> = 8.1 Hz, 2 H), 7.05 (dd, <i>J</i> = 11.7, 8.8 Hz, 1 H), 7.89 (dd, <i>J</i> = 6.8, 2.8 Hz, 1 H), 8.04 (ddd, <i>J</i> = 8.7, 4.1, 2.9 Hz, 1 H), 8.30 (d, <i>J</i> = 1.2 Hz, 1 H), 9.03 (d, <i>J</i> = 1.2 Hz, 1 H), 9.52 (s, 1 H). LC-MS <i>m</i>/<i>z</i> 496 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −15 (<i>c</i> = 0.48 in DMF).</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-{3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-(2,2,3,3,3-pentafluoropropoxy)pyrazine-2-carboxamide (<b>28</b>)</h4><div class="NLM_p last">Starting from aniline <b>16</b> (0.10 g, 0.34 mmol) and 5-(2,2,3,3,3-pentafluoropropoxy)pyrazine-pyrazine-2-carboxylic acid (CAS 1867198-33-1; 93 mg, 0.34 mmol), following the same procedure as for <b>3</b>, the corresponding <b>28</b> was obtained as a solid (100 mg, 53% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ ppm 1.68 (d, <i>J</i> = 0.7 Hz, 3H), 4.06–4.53 (m, 4H), 4.66 (q, <i>J</i> = 8.3 Hz, 1H), 4.85–4.98 (m, 2H), 7.06 (dd, <i>J</i> = 11.6, 8.8 Hz, 1H), 7.90 (dd, <i>J</i> = 6.7, 2.8 Hz, 1H), 8.02 (ddd, <i>J</i> = 8.8, 4.2, 2.9 Hz, 1H), 8.30 (d, <i>J</i> = 1.4 Hz, 1H), 9.03 (d, <i>J</i> = 1.4 Hz, 1H), 9.53 (s, 1H). LC-MS <i>m</i>/<i>z</i> 546 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −10.1 (<i>c</i> = 0.62 in DMF); mp = 168.9 °C.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-{3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-[(2,2,2-trifluoroethyl)amino]-pyrazine-2-carboxamide (<b>29</b>)</h4><div class="NLM_p last">Starting from aniline <b>16</b> (0.10 g, 0.34 mmol) and 5-[(2,2,2-trifluoroethyl)amino]-pyrazine-2-carboxylic acid (CAS 1339604-08-8; 76 mg, 0.34 mmol), following the same procedure as for <b>3</b>, the corresponding <b>29</b> was obtained as a solid (60 mg, 35% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 1.69 (s, 3 H), 4.20–4.30 (m, 4 H), 4.37 (br s, 2 H), 4.66 (q, <i>J</i> = 8.4 Hz, 1 H), 5.26 (br t, <i>J</i> = 6.5 Hz, 1 H), 7.05 (dd, <i>J</i> = 11.6, 9.0 Hz, 1 H), 7.88 (dd, <i>J</i> = 6.8, 2.8 Hz, 1 H), 7.91 (d, <i>J</i> = 1.2 Hz, 1 H), 8.01 (ddd, <i>J</i> = 8.7, 4.3, 2.9 Hz, 1 H), 8.96 (d, <i>J</i> = 1.4 Hz, 1 H), 9.45 (s, 1 H). LC-MS <i>m</i>/<i>z</i> 495 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −5.5 (<i>c</i> = 0.53 in DMF).</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-{3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-(cyclopropylamino)pyrazine-2-carboxamide (<b>30</b>)</h4><div class="NLM_p last">Starting from aniline <b>16</b> (0.10 g, 0.34 mmol) and 5-(cyclopropylamino)pyrazine-2-carboxylic acid (CAS 1343976-96-4; 62 mg, 0.34 mmol), following the same procedure as for <b>3</b>, the corresponding <b>30</b> was obtained as a solid (90 mg, 58% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>): δ ppm 0.64–0.72 (m, 2H), 0.87–0.99 (m, 2H), 1.69 (s, 3H), 2.70 (dddt, <i>J</i> = 8.4, 5.0, 3.5, 1.8, 1.8 Hz, 1H), 4.20–4.43 (m, 4H), 4.66 (q, <i>J</i> = 8.1 Hz, 1H), 5.50 (s, 1H), 7.04 (dd, <i>J</i> = 11.7, 8.8 Hz, 1H), 7.88 (dd, <i>J</i> = 6.6, 2.9 Hz, 1H), 8.03 (ddd, <i>J</i> = 8.7, 4.3, 2.9 Hz, 1H), 8.10 (d, <i>J</i> = 1.2 Hz, 1H), 8.92 (d, <i>J</i> = 1.4 Hz, 1H), 9.48 (s, 1H). LC-MS <i>m</i>/<i>z</i> 453 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −2.7 (<i>c</i> = 0.5 in DMF); mp = 151.4 °C.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-{3-[(2<i>R,</i>3<i>R</i>)-5-Amino-3-methyl-2-(trifluoromethyl)-3,6-dihydro-2<i>H</i>-1,4-oxazin-3-yl]-4-fluorophenyl}-5-(azetidin-1-yl)pyrazine-2-carboxamide (<b>31</b>)</h4><div class="NLM_p last">Starting from aniline <b>16</b> (90 mg, 0.31 mmol) and 5-(azetidin-1-yl)pyrazine-2-carboxylic acid (CAS 1850944-74-9; 55 mg, 0.31 mmol), following the same procedure as for <b>3</b>, the corresponding <b>31</b> was obtained as a solid (30 mg, 21% yield). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.54 (s, 3H), 2.38–2.46 (m, 2H), 4.07–4.13 (m, 1H), 4.13–4.24 (m, 5H), 4.53 (q, <i>J</i> = 8.3 Hz, 1H), 5.84 (s, 2H), 7.08 (dd, <i>J</i> = 12.0, 8.8 Hz, 1H), 7.77 (dt, <i>J</i> = 8.7, 3.5 Hz, 1H), 7.83 (d, <i>J</i> = 1.4 Hz, 1H), 8.11 (dd, <i>J</i> = 7.2, 2.9 Hz, 1H), 8.68 (d, <i>J</i> = 1.4 Hz, 1H), 10.10 (s, 1H). LC-MS <i>m</i>/<i>z</i> 453 [M + H]<sup>+</sup>; [α]<sup>20</sup><sub>D</sub> = −0.7 (<i>c</i> = 0.5 in DMF); mp = 276 °C.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Biology</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> In Vitro Pharmacology: Enzymatic BACE1 Assay</h4><div class="NLM_p last">Primary BACE1 enzymatic activity was assessed by a FRET assay using an amyloid precursor protein (APP) derived 13 amino acids peptide that contains the “Swedish” Lys-Met/Asn-Leu mutation of the APP β-secretase cleavage site as a substrate (Bachem catalogue no. M-2465) and soluble BACE1(1–454) (Aurigene, Custom made). This substrate contains two fluorophores: (7-methoxycoumarin-4-yl) acetic acid (Mca) is a fluorescent donor with excitation wavelength at 320 nm and emission at 405 nm and 2,4-dinitrophenyl (Dnp) is a proprietary quencher acceptor. The increase in fluorescence was linearly related to the rate of proteolysis. In a 384-well format, BACE1 was incubated with the substrate and the inhibitor. The amount of proteolysis was directly measured by fluorescence measurement in the Fluoroskan microplate fluorometer (Thermo scientific). For the low control, no enzyme was added to the reaction mixture.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Cellular Aβ Assay</h4><div class="NLM_p last">Cellular activity was assessed using a SKNBE2 (human) or Neuro-2a (mouse) neuroblastoma cell line expressing the wild-type amyloid precursor protein (hAPP695). The compounds are diluted and added to these cells, incubated for 18 h, and then measurements of Aβ42 and Aβtotal were taken. Aβ42 and Aβtotal were measured by a sandwich αlisa assay using biotinylated antibody (AbN/25) attached to streptavidin-coated beads and antibody (cAb42/26) conjugated acceptor beads. In the presence of Aβ42, the beads come into proximity. The excitation of the donor beads provokes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the acceptor beads, resulting in light emission.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> In Vivo Pharmacology</h4><div class="NLM_p last">All in vivo experimental procedures were performed according to the applicable Directive 2010/63/EU of the European Parliament and of the Council of September 22, 2010 on the protection of animals used for scientific purposes and approved by the local ethical committee.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Mouse PK and Aβ Quantification</h4><div class="NLM_p last">Male CD1 Swiss specific pathogen free (SPF) mice (Charles River Company, Germany) were dosed po or sc with the formulated (20% HPβCD) compound. After the indicated time of treatment, the animals were sacrificed and Aβ levels were analyzed. Blood was collected by decapitation and exsanguinations in EDTA-treated collection tubes. Blood was centrifuged at 1900<i>g</i> for 10 min at 4 °C and the plasma recovered and flash frozen for later analysis. The brain was removed from the cranium and hindbrain. The cerebellum was removed, and the left and right hemisphere were separated. The left hemisphere was stored at −18 °C for quantitative analysis of test compound levels. The right hemisphere was rinsed with phosphate buffered saline (PBS) buffer and immediately frozen on dry ice and stored at −80 °C until homogenization for biochemical assays. The other hemisphere was homogenized, centrifuged, and processed for the quantification of Aβ total and Aβ42 via ELISA as described previously.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Briefly, for the quantification of Aβtotal Aβ42 the antibody pair JRF/rAb/2 and 4G8 or JRF/cAb42/26 and JRF/rAb/2 antibody was used for capturing and detection, respectively. <i>K</i><sub>p</sub> values were calculated by dividing brain compound levels and plasma compound levels at the same time point, and <i>K</i><sub>p(u,u)</sub> was derived by multiplying <i>K</i><sub>p</sub> by the ratio of fraction inbound in (rat) brain over fraction unbound in (mouse) plasma, assuming consistency across species for brain tissue binding.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Dog in Vivo PK and Aβ Quantification</h4><div class="NLM_p last">Female beagle dogs are dosed p.o. with the formulated (20% HPβCD) compound or vehicle. At the indicated time points CSF was sampled in conscious dogs from the lateral ventricle. Quantification of Aβ42 in dog CSF was performed using MesoScale Discovery (MSD)’s electrochemiluminescence detection technology as described previously.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00304" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14082" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14082" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00304" class="ext-link">10.1021/acs.jmedchem.8b00304</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">All additional pharmacological profiling protocols: hERG patch-clamp; microsomal metabolic stability; hepatocyte metabolic stability; CYP450 inhibition; plasma protein binding; nonspecific binding to brain tissue; in vitro permeability/P-gp efflux; p<i>K</i><sub>a</sub> and log <i>D</i> assay; high content screen cytotoxicity assay with HepG2-cells; in vitro phospholipidosis; in vitro selectivity profile (CEREP); in vivo PK and toxicology studies: PK studies in mouse, rat, and dog; cardio-hemodynamic and cardio-electrophysiological effects in anesthetized guinea pigs; one-month GLP toxicity studies; <sup>1</sup>H-NOESY and <sup>19</sup>F-<sup>1</sup>H NOESY data for <b>25</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">List of molecular formula strings and the associated biochemical and biological data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_001.pdf">jm8b00304_si_001.pdf (654.01 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_002.csv">jm8b00304_si_002.csv (2.23 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00304" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Harrie J. M. Gijsen</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8020-4828" title="Orcid link">http://orcid.org/0000-0001-8020-4828</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f79f909e9d849299b79e8384d99d999dd994989a"><span class="__cf_email__" data-cfemail="bcd4dbd5d6cfd9d2fcd5c8cf92d6d2d692dfd3d1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergio A. Alonso de Diego</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen−Cilag SA, C/Jarama 75A, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel De Cleyn</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aránzazu García-Molina</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen−Cilag SA, C/Jarama 75A, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregor J. Macdonald</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolina Martínez-Lamenca</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Oehlrich</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3392-1952" title="Orcid link">http://orcid.org/0000-0002-3392-1952</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hana Prokopcova</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederik J. R. Rombouts</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1986-0476" title="Orcid link">http://orcid.org/0000-0003-1986-0476</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Surkyn</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrés
A. Trabanco</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen−Cilag SA, C/Jarama 75A, 45007 Toledo, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4225-758X" title="Orcid link">http://orcid.org/0000-0002-4225-758X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sven Van Brandt</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dries Van den Bossche</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michiel Van Gool</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research & Development, Janssen−Cilag SA, C/Jarama 75A, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel Austin</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Herman Borghys</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deborah Dhuyvetter</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diederik Moechars</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Biology, Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d165e3756-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80842" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80842" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the analytical departments in Beerse and Toledo for helping with compound characterization and purification and the DMPK and toxicology departments for their contributions in profiling the compounds. D.V.d.B. was supported by a grant (IWT 145058) from Flanders Innovation & Entrepreneurship (VLAIO), Belgium.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">GLP</td><td class="NLM_def"><p class="first last">good laboratory practices</p></td></tr><tr><td class="NLM_term">hERG PC</td><td class="NLM_def"><p class="first last">hERG</p></td></tr><tr><td class="NLM_term">patch clamp hLM or mLM</td><td class="NLM_def"><p class="first last">human or mouse liver microsomes</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">nd</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">DMTMM</td><td class="NLM_def"><p class="first last">4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride</p></td></tr><tr><td class="NLM_term">TBAT</td><td class="NLM_def"><p class="first last">tetrabutylammonium difluorotriphenylsilicate</p></td></tr><tr><td class="NLM_term">DMEDA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dimethylethylenediamine</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-ferrocenediyl-bis(diphenylphosphine)</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>u</sub>,p</td><td class="NLM_def"><p class="first last">free (unbound) fraction in plasma</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>u,b</sub></td><td class="NLM_def"><p class="first last">fraction unbound in brain tissue</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>p</sub></td><td class="NLM_def"><p class="first last">brain-to-plasma ratio</p></td></tr><tr><td class="NLM_term">TDI</td><td class="NLM_def"><p class="first last">time dependent inhibition</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">Vd<sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term">LBF</td><td class="NLM_def"><p class="first last">liver blood flow</p></td></tr><tr><td class="NLM_term">NOAEL</td><td class="NLM_def"><p class="first last">no observed adverse effect level</p></td></tr><tr><td class="NLM_term">LOAEL</td><td class="NLM_def"><p class="first last">lowest observed adverse effect level</p></td></tr><tr><td class="NLM_term">MNT</td><td class="NLM_def"><p class="first last">micronucleus test</p></td></tr><tr><td class="NLM_term">THP-1</td><td class="NLM_def"><p class="first last">human leukemic monocyte cell line</p></td></tr><tr><td class="NLM_term">HPβCD</td><td class="NLM_def"><p class="first last">(2-hydroxypropyl)-β-cyclodextrin [128446-35-5]</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 21 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <i>World Alzheimer
Report 2016</i>; <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2016</span>; <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf</a> (accessed May 7, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+World+Alzheimer%0AReport+2016%3B+Alzheimer%E2%80%99s+Disease+International%3A+London%2C+2016%3B+https%3A%2F%2Fwww.alz.co.uk%2Fresearch%2FWorldAlzheimerReport2016.pdf+%28accessed+May+7%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Alzheimer%250AReport%25202016%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, O. L.</span></span> <span> </span><span class="NLM_article-title">The growing burden of Alzheimer’s disease</span>. <i>Am. J. Manag. Care</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">S339</span>– <span class="NLM_lpage">S345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=22214391" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=S339-S345&author=O.+L.+Lopez&title=The+growing+burden+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DO.%2BL.%26atitle%3DThe%2520growing%2520burden%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Manag.%2520Care%26date%3D2011%26volume%3D17%26spage%3DS339%26epage%3DS345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marešová, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohelská, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolejš, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuča, K.</span></span> <span> </span><span class="NLM_article-title">Socio-economic aspects of Alzheimer’s disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">903</span>– <span class="NLM_lpage">911</span>, <span class="refDoi"> DOI: 10.2174/156720501209151019111448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.2174%2F156720501209151019111448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=26510983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGitbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=903-911&author=P.+Mare%C5%A1ov%C3%A1author=H.+Mohelsk%C3%A1author=J.+Dolej%C5%A1author=K.+Ku%C4%8Da&title=Socio-economic+aspects+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F156720501209151019111448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Socio-economic Aspects of Alzheimer's Disease</span></div><div class="casAuthors">Maresova, Petra; Mohelska, Hana; Dolejs, Josef; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">903-911</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Social development, better living conditions and medical advances lead to the fact that more people have the opportunity to live longer than in the past.  The aging population is a characteristic feature of demog. trends in developed countries.  This trend is closely linked with the issue of increasing no. of diseases in old age and increasing government expenditure on health and social care.  The most frequently mentioned diseases in old age include dementia.  The cause may lie in all kinds of diseases, the most common are Alzheimer's disease and cerebrovascular disease.  Now the care of current 35 million patients with dementia costs over $ 600 billion per yr, it is approx. one percent of global Gross Domestic Product.  This review discusses the recent issues and questions in the area of social and economic aspects of Alzheimer's disease.  It focuses in detail on the national strategies in the approach to Alzheimer's disease, the anticipated problems concerning the insufficient no. of social workers and necessary expenses of state budgets in the future.  The situation in the area of health insurance companies' expenditures is illustrated in the context of the anal. of long-term care systems, in the chosen countries within the European Union.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoiq1ROmJCe7Vg90H21EOLACvtfcHk0lj4mCXxskT-xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGitbvO&md5=625e48233fdd8829da1631aa173fcf8d</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.2174%2F156720501209151019111448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720501209151019111448%26sid%3Dliteratum%253Aachs%26aulast%3DMare%25C5%25A1ov%25C3%25A1%26aufirst%3DP.%26aulast%3DMohelsk%25C3%25A1%26aufirst%3DH.%26aulast%3DDolej%25C5%25A1%26aufirst%3DJ.%26aulast%3DKu%25C4%258Da%26aufirst%3DK.%26atitle%3DSocio-economic%2520aspects%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2015%26volume%3D12%26spage%3D903%26epage%3D911%26doi%3D10.2174%2F156720501209151019111448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span> <span> </span><span class="NLM_article-title">Advances in Our Understanding of the Pathophysiology of Alzheimer’s Disease</span>. <i>US Neurology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.17925/USN.2010.06.01.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.17925%2FUSN.2010.06.01.28" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=28-31&author=K.+N.+Greenauthor=S.+Schreiber&title=Advances+in+Our+Understanding+of+the+Pathophysiology+of+Alzheimer%E2%80%99s+Disease&doi=10.17925%2FUSN.2010.06.01.28"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.17925%2FUSN.2010.06.01.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.17925%252FUSN.2010.06.01.28%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DK.%2BN.%26aulast%3DSchreiber%26aufirst%3DS.%26atitle%3DAdvances%2520in%2520Our%2520Understanding%2520of%2520the%2520Pathophysiology%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DUS%2520Neurology%26date%3D2010%26volume%3D6%26spage%3D28%26epage%3D31%26doi%3D10.17925%2FUSN.2010.06.01.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swerdlow, R. H.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis of Alzheimer’s disease</span>. <i>Clin. Interv. Aging</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=18044185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOltbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=347-359&author=R.+H.+Swerdlow&title=Pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Swerdlow, Russell H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-359</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is incredibly common.  Increasing longevity ensures its prevalence will rise even further.  Ongoing efforts to understand AD pathogenesis reveal numerous tantalizing leads.  Formulating a comprehensive AD pathogenesis theory capable of incorporating these disparate leads, though, has proven difficult.  This review discusses current attempts to formulate a comprehensive AD pathogenesis theory.  In doing so, it focuses on clin. and mol. relationships between AD and aging.  A better understanding of these relationships could inform and impact future development of AD-directed treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDTJfub3KthrVg90H21EOLACvtfcHk0lj4mCXxskT-xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOltbrF&md5=44564cf07c3c020d4feb627f64654d86</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwerdlow%26aufirst%3DR.%2BH.%26atitle%3DPathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Interv.%2520Aging%26date%3D2007%26volume%3D2%26spage%3D347%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0likXJT45QCYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+A.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0likXJT45QCYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0likXJT45QCYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendran, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span> <span> </span><span class="NLM_article-title">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1111/jnc.12715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1111%2Fjnc.12715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=24646365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=4-28&author=R.+Vassarauthor=P.-H.+Kuhnauthor=C.+Haassauthor=M.+E.+Kennedyauthor=L.+Rajendranauthor=P.+C.+Wongauthor=S.+F.+Lichtenthaler&title=Function%2C+therapeutic+potential+and+cell+biology+of+BACE+proteases%3A+current+status+and+future+prospects&doi=10.1111%2Fjnc.12715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span></div><div class="casAuthors">Vassar, Robert; Kuhn, Peer-Hendrik; Haass, Christian; Kennedy, Matthew E.; Rajendran, Lawrence; Wong, Philip C.; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-28</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The β-site APP cleaving enzymes 1 and 2 (BACE1 and BACE2) were initially identified as transmembrane aspartyl proteases cleaving the amyloid precursor protein (APP).  BACE1 is a major drug target for Alzheimer's disease because BACE1-mediated cleavage of APP is the first step in the generation of the pathogenic amyloid-β peptides.  BACE1, which is highly expressed in the nervous system, is also required for myelination by cleaving neuregulin 1.  Several recent proteomic and in vivo studies using BACE1- and BACE2-deficient mice demonstrate a much wider range of physiol. substrates and functions for both proteases within and outside of the nervous system.  For BACE1 this includes axon guidance, neurogenesis, muscle spindle formation, and neuronal network functions, whereas BACE2 was shown to be involved in pigmentation and pancreatic β-cell function.  This review highlights the recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer's disease.  The protease BACE1 is a major drug target in Alzheimer disease.  Together with its homolog BACE2, both proteases have an increasing no. of functions within and outside of the nervous system.  This review highlights recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxkCRjc9dYMLVg90H21EOLACvtfcHk0likXJT45QCYUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M&md5=79e394bb720ad6639f8efc86138fcd60</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12715%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKuhn%26aufirst%3DP.-H.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DRajendran%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DFunction%252C%2520therapeutic%2520potential%2520and%2520cell%2520biology%2520of%2520BACE%2520proteases%253A%2520current%2520status%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D130%26spage%3D4%26epage%3D28%26doi%3D10.1111%2Fjnc.12715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-secretase (BACE) for the treatment of Alzheimer’s disease</span>, In  <i>Comprehensive Medicinal Chemistry III</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26spage%3D326%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0lgpprAjeVM9MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowman Rogers, M.</span></span> <i>Merck Axes Verubecestat for Prodromal AD, Researchers Say ‘Go Earlier’</i>; <span class="NLM_publisher-name">Alzforum</span>, <span class="NLM_year">2018</span>; <a href="https://www.alzforum.org/news/research-news/merck-axes-verubecestat-prodromal-ad-researchers-say-go-earlier" class="extLink">https://www.alzforum.org/news/research-news/merck-axes-verubecestat-prodromal-ad-researchers-say-go-earlier</a> (accessed May 7, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Bowman+Rogers&title=Merck+Axes+Verubecestat+for+Prodromal+AD%2C+Researchers+Say+%E2%80%98Go+Earlier%E2%80%99"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%2BRogers%26aufirst%3DM.%26jtitle%3DMerck%2520Axes%2520Verubecestat%2520for%2520Prodromal%2520AD%252C%2520Researchers%2520Say%2520%25E2%2580%2598Go%2520Earlier%25E2%2580%2599%26pub%3DAlzforum%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salihoglu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blume, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorostkar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1007/s00401-017-1804-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1007%2Fs00401-017-1804-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2018&pages=695-710&author=F.+Petersauthor=H.+Salihogluauthor=E.+Rodriguesauthor=E.+Herzogauthor=T.+Blumeauthor=S.+Filserauthor=M.+Dorostkarauthor=D.+R.+Shimshekauthor=N.+Broseauthor=U.+Neumannauthor=J.+Herms&title=BACE1+inhibition+more+effectively+suppresses+initiation+than+progression+of+%CE%B2-amyloid+pathology&doi=10.1007%2Fs00401-017-1804-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1007%2Fs00401-017-1804-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-017-1804-9%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DF.%26aulast%3DSalihoglu%26aufirst%3DH.%26aulast%3DRodrigues%26aufirst%3DE.%26aulast%3DHerzog%26aufirst%3DE.%26aulast%3DBlume%26aufirst%3DT.%26aulast%3DFilser%26aufirst%3DS.%26aulast%3DDorostkar%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DBrose%26aufirst%3DN.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DHerms%26aufirst%3DJ.%26atitle%3DBACE1%2520inhibition%2520more%2520effectively%2520suppresses%2520initiation%2520than%2520progression%2520of%2520%25CE%25B2-amyloid%2520pathology%26jtitle%3DActa%2520Neuropathol.%26date%3D2018%26volume%3D135%26spage%3D695%26epage%3D710%26doi%3D10.1007%2Fs00401-017-1804-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Reiman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langbaum, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopera, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roses, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh-Bohmer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weninger, S.</span></span> <span> </span><span class="NLM_article-title">CAP – advancing the evaluation of preclinical Alzheimer disease treatments</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2015.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1038%2Fnrneurol.2015.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=26416539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Slt7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=56-61&author=E.+M.+Reimanauthor=J.+B.+Langbaumauthor=P.+N.+Tariotauthor=F.+Loperaauthor=R.+J.+Batemanauthor=J.+C.+Morrisauthor=R.+A.+Sperlingauthor=P.+S.+Aisenauthor=A.+D.+Rosesauthor=K.+A.+Welsh-Bohmerauthor=M.+C.+Carrilloauthor=S.+Weninger&title=CAP+%E2%80%93+advancing+the+evaluation+of+preclinical+Alzheimer+disease+treatments&doi=10.1038%2Fnrneurol.2015.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">CAP-advancing the evaluation of preclinical Alzheimer disease treatments</span></div><div class="casAuthors">Reiman, Eric M.; Langbaum, Jessica B.; Tariot, Pierre N.; Lopera, Francisco; Bateman, Randall J.; Morris, John C.; Sperling, Reisa A.; Aisen, Paul S.; Roses, Allen D.; Welsh-Bohmer, Kathleen A.; Carrillo, Maria C.; Weninger, Stacie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-61</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  If the authors are to find treatments to postpone, reduce the risk of, or completely prevent the clin. onset of Alzheimer disease (AD), the authors need faster methods to evaluate promising preclin. AD treatments, new ways to work together in support of common goals, and a detn. to expedite the initiation and performance of preclin. AD trials.  In this article, the authors note some of the current challenges, opportunities and emerging strategies in preclin. AD treatment.  The authors describe the Collaboration for Alzheimer's Prevention (CAP)-a convening, harmonizing and consensus-building initiative to help stakeholders advance AD prevention research with rigor, care and maximal impact-and the authors demonstrate the impact of CAP on the goals and design of new preclin. AD trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwWEUYE-RaibVg90H21EOLACvtfcHk0lgpprAjeVM9MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Slt7nF&md5=07952464ae96afd026af6cc888c9dcd8</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2015.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2015.177%26sid%3Dliteratum%253Aachs%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DLangbaum%26aufirst%3DJ.%2BB.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DLopera%26aufirst%3DF.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26aulast%3DWelsh-Bohmer%26aufirst%3DK.%2BA.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DWeninger%26aufirst%3DS.%26atitle%3DCAP%2520%25E2%2580%2593%2520advancing%2520the%2520evaluation%2520of%2520preclinical%2520Alzheimer%2520disease%2520treatments%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2016%26volume%3D12%26spage%3D56%26epage%3D61%26doi%3D10.1038%2Fnrneurol.2015.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de
Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: from hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de%0ADiegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-Secretase+1+%28BACE1%29+Inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0lj4-kKnO1LrWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-Secretase%25201%2520%2528BACE1%2529%2520Inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clerck, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van De Water, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Aubioul, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rossem, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ammel, K.</span></span> <span> </span><span class="NLM_article-title">In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to preclinical cardiovascular safety pharmacology of a new chemical entity</span>. <i>Fundam. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1046/j.1472-8206.2002.00081.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1046%2Fj.1472-8206.2002.00081.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=12031065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFOrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=125-139&author=F.+De%0AClerckauthor=A.+Van+De+Waterauthor=J.+D%E2%80%99Aubioulauthor=H.+R.+Luauthor=K.+van+Rossemauthor=A.+Hermansauthor=K.+Van+Ammel&title=In+vivo+measurement+of+QT+prolongation%2C+dispersion+and+arrhythmogenesis%3A+application+to+preclinical+cardiovascular+safety+pharmacology+of+a+new+chemical+entity&doi=10.1046%2Fj.1472-8206.2002.00081.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: Application to the preclinical cardiovascular safety pharmacology of a new chemical entity</span></div><div class="casAuthors">De Clerck, Fred; Van de Water, Andre; D'Aubioul, Jan; Lu, Hua Rong; van Rossem, Koen; Hermans, An; Van Ammel, Karel</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-140</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In addn. to in silico and in vitro measurements, cardiac electrophysiol. in exptl. animals plays a decisive role in the selection of a potential "cardio-safe" new chem. entity (NCE).  The present synopsis critically reviews such in vivo techniques in exptl. animals.  In anesthetized guinea-pigs, surface eCG recordings readily identify the typical effects of Class I to IV anti-arrhythmic compds. and of If blockers such as zatebradine on eCG intervals and morphol., but also of non-cardiovascular NCEs affecting cardiac elec. activity via ion channels or neurogenic mechanisms.  QT/RR plots indicate that bradycardia is a dominant effect of IKr blockers (dual modulation by IKr of sinus node activity and ventricular repolarization).  Nevertheless, correction of QT with Bazett's formula usually distinguishes between drug-induced heart rate redn. and real prolongation of ventricular repolarization (QTc).  The anesthetized guinea-pig model thus is a useful tool for first line in vivo testing of an NCE for effects on cardiac electrophysiol., in particular when combined with measurements of drug levels in plasma and heart tissues.  In anesthetized dogs, advanced eCG analyses identify drug-induced effects on atrial and ventricular intervals, on temporal and transmural dispersion of ventricular repolarization and on incidences of early after-depolarizations.  This can be combined with complete hemodynamic, pulmonary and pharmacokinetic analyses in one prepn.  However, compd. doses/plasma levels needed for effects on ventricular repolarization in this model are substantially higher than those identified in guinea-pigs, at least for IKr blocking compds.  Therefore, the authors use this "information-rich" canine model as a second line approach.  In awake, trained and appropriately instrumented dogs, readings of surface eCG in combination with cardio-hemodynamic and behavioral assessments can be performed after the administration of an NCE via the expected therapeutic route, including oral medication.  However, at higher doses the compd. under scrutiny may induce overall behavioral side-effects, related to its primary pharmacol. action, such as gastrokinetic repercussions or CNS-mediated sedation or excitation.  Such primary pharmacol. effects are bound to compromise the evaluation of real drug-induced changes on cardiac electrophysiol., readily identified by resource-friendly setups in smaller animals.  Therefore, the authors use such paradigms as an imperative, final cardiovascular check-up, before a "First in Man" administration of the NCE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbEqHYy5WNvLVg90H21EOLACvtfcHk0lj4-kKnO1LrWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFOrurY%253D&md5=b12da3b167ed603fe3239b6285ce0122</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1046%2Fj.1472-8206.2002.00081.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1472-8206.2002.00081.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClerck%26aufirst%3DF.%26aulast%3DVan%2BDe%2BWater%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Aubioul%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DH.%2BR.%26aulast%3Dvan%2BRossem%26aufirst%3DK.%26aulast%3DHermans%26aufirst%3DA.%26aulast%3DVan%2BAmmel%26aufirst%3DK.%26atitle%3DIn%2520vivo%2520measurement%2520of%2520QT%2520prolongation%252C%2520dispersion%2520and%2520arrhythmogenesis%253A%2520application%2520to%2520preclinical%2520cardiovascular%2520safety%2520pharmacology%2520of%2520a%2520new%2520chemical%2520entity%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D16%26spage%3D125%26epage%3D139%26doi%3D10.1046%2Fj.1472-8206.2002.00081.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of two different methods for measurement of amyloid-beta peptides in cerebrospinal fluid after BACE1 inhibition in a dog model</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.3233/JAD-130599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.3233%2FJAD-130599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=23948925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs12mu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=39-48&author=H.+Borghysauthor=T.+Jacobsauthor=B.+Van+Broeckauthor=L.+Dillenauthor=D.+Dhuyvetterauthor=H.+Gijsenauthor=M.+Mercken&title=Comparison+of+two+different+methods+for+measurement+of+amyloid-beta+peptides+in+cerebrospinal+fluid+after+BACE1+inhibition+in+a+dog+model&doi=10.3233%2FJAD-130599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Two Different Methods for Measurement of Amyloid-β Peptides in Cerebrospinal Fluid after BACE1 Inhibition in a Dog Model</span></div><div class="casAuthors">Borghys, Herman; Jacobs, Tom; Van Broeck, Bianca; Dillen, Lieve; Dhuyvetter, Deborah; Gijsen, Harrie; Mercken, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-48</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Beta-secretase is the first cleavage enzyme of amyloid-β protein precursor (AβPP) in the amyloidogenic pathway, leading to the formation of the plaque forming Amyloid-β (Aβ)1-42 peptide.  BACE (beta-site AβPP cleaving enzyme) 1 inhibition is therefore considered to be a promising disease modifying therapy for Alzheimer's disease.  An early assessment of the in vivo activity of BACE inhibitors was done in dogs since AβPP processing is the same as in humans and this species easily enables longitudinal cerebrospinal fluid (CSF) sampling.  Aβ changes in CSF compared to baseline are used to evaluate target engagement of the compds.  Levels of Aβ1-37, Aβ1-38, Aβ1-40, and Aβ1-42 in CSF are measured with immunoassay (Mesoscale electrochemiluminescence technol.) and with an ultra high-performance liq. chromatog. mass spectrometry (UPLC-MS/MS).  Two exptl. BACE inhibitors were evaluated.  With the immunoassay, a dose dependent decrease is obsd. for all four Aβ peptides.  Measurements with the UPLC-MS/MS are in line with the immunoassay for Aβ1-37, Aβ1-38, and Aβ1-40, however, for Aβ1-42, differences are sometimes obsd. when comparing to changes seen in the other peptides with UPLC-MS/MS and with immunoassay results.  Generally lower concns. are measured with immunoassay.  The reason for these differences is still unknown.  Aβ1-42 is more prone to form aggregates compared to the other peptides.  One hypothesis could be that while the immunoassay only measures free Aβ, bound and aggregated Aβ peptides are at least partially dissolved with the UPLC-MS/MS method, since acetonitrile is added to the CSF samples.  This increases variability in the concn. of Aβ peptide measured with UPLC-MS/MS, esp. for Aβ1-42, potentially masking the compd. effect on Aβ1-42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_u_w4V1IufLVg90H21EOLACvtfcHk0lhD4Hu60QwCPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs12mu7zN&md5=06649719f3ab8f260dda2f62a3ed2c42</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3233%2FJAD-130599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130599%26sid%3Dliteratum%253Aachs%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DJacobs%26aufirst%3DT.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DComparison%2520of%2520two%2520different%2520methods%2520for%2520measurement%2520of%2520amyloid-beta%2520peptides%2520in%2520cerebrospinal%2520fluid%2520after%2520BACE1%2520inhibition%2520in%2520a%2520dog%2520model%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D39%26epage%3D48%26doi%3D10.3233%2FJAD-130599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, C.</span></span> <span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1759</span>– <span class="NLM_lpage">1764</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity&doi=10.1016%2Fj.bmcl.2006.12.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0lhD4Hu60QwCPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764%26doi%3D10.1016%2Fj.bmcl.2006.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> cLogP values for the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> were calculated using Biobyte
software (<a href="http://www.biobyte.com" class="extLink">www.biobyte.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+cLogP+values+for+the+compounds+in+Table+2+were+calculated+using+Biobyte%0Asoftware+%28www.biobyte.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawachi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasaki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, S.</span></span> <span> </span><span class="NLM_article-title">4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride: an efficient condensing agent leading to the formation of amides and esters</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">13159</span>– <span class="NLM_lpage">13170</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(99)00809-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2FS0040-4020%2899%2900809-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADyaK1MXntV2qtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=13159-13170&author=M.+Kunishimaauthor=C.+Kawachiauthor=J.+Montaauthor=K.+Teraoauthor=F.+Iwasakiauthor=S.+Tani&title=4-%284%2C6-dimethoxy-1%2C3%2C5-triazin-2-yl%29-4-methyl-morpholinium+chloride%3A+an+efficient+condensing+agent+leading+to+the+formation+of+amides+and+esters&doi=10.1016%2FS0040-4020%2899%2900809-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride: an efficient condensing agent leading to the formation of amides and esters</span></div><div class="casAuthors">Kunishima, Munetaka; Kawachi, Chiho; Morita, Jun; Terao, Keiji; Iwasaki, Fumiaki; Tani, Shohei</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">13159-13170</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM) was quant. synthesized by the coupling of 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and N-methylmorpholine (NMM) in THF, and characterized.  Condensation of carboxylic acids and amines by DMTMM proceeded effectively in THF to give the corresponding amides in good yields.  The corresponding esters can be obtained by esterification of carboxylic acids with DMTMM in methanol, ethanol, iso-Pr alc., or t-Bu alc. in the presence of NMM.  The amt. of alcs. can be reduced to a stoichiometric amt. by conducting the reaction in THF.  Since the reactions proceed under atm. conditions without drying of the solvent, and the co-product (4,6-dimethoxy-1,3,5-triazin-2(1H)-one) arising from DMTMM after condensation can be readily removed by extn., this method is a very practical one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKXgxk6cGvMLVg90H21EOLACvtfcHk0lhD4Hu60QwCPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntV2qtb0%253D&md5=ffff2540367541c869f4661cb6407267</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2899%2900809-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252899%252900809-1%26sid%3Dliteratum%253Aachs%26aulast%3DKunishima%26aufirst%3DM.%26aulast%3DKawachi%26aufirst%3DC.%26aulast%3DMonta%26aufirst%3DJ.%26aulast%3DTerao%26aufirst%3DK.%26aulast%3DIwasaki%26aufirst%3DF.%26aulast%3DTani%26aufirst%3DS.%26atitle%3D4-%25284%252C6-dimethoxy-1%252C3%252C5-triazin-2-yl%2529-4-methyl-morpholinium%2520chloride%253A%2520an%2520efficient%2520condensing%2520agent%2520leading%2520to%2520the%2520formation%2520of%2520amides%2520and%2520esters%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D13159%26epage%3D13170%26doi%3D10.1016%2FS0040-4020%2899%2900809-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allison, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span> <span> </span><span class="NLM_article-title">Gram-scale synthesis of a beta-secretase 1 (BACE 1) inhibitor</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1021/acsomega.6b00362</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.6b00362" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=397-408&author=B.+D.+Allisonauthor=N.+S.+Mani&title=Gram-scale+synthesis+of+a+beta-secretase+1+%28BACE+1%29+inhibitor&doi=10.1021%2Facsomega.6b00362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsomega.6b00362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.6b00362%26sid%3Dliteratum%253Aachs%26aulast%3DAllison%26aufirst%3DB.%2BD.%26aulast%3DMani%26aufirst%3DN.%2BS.%26atitle%3DGram-scale%2520synthesis%2520of%2520a%2520beta-secretase%25201%2520%2528BACE%25201%2529%2520inhibitor%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26spage%3D397%26epage%3D408%26doi%3D10.1021%2Facsomega.6b00362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith LaBell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lh47a17Qp6tjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLaBell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman Rogers, M.</span></span> <i>Lilly Halts Phase 2 Trial of BACE Inhibitor Due to Liver Toxicity</i>; <span class="NLM_publisher-name">Alzforum</span>, <span class="NLM_year">2013</span>; <a href="https://www.alzforum.org/news/research-news/lilly-halts-phase-2-trial-bace-inhibitor-due-liver-toxicity" class="extLink">https://www.alzforum.org/news/research-news/lilly-halts-phase-2-trial-bace-inhibitor-due-liver-toxicity</a> (accessed May 7, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Bowman+Rogers&title=Lilly+Halts+Phase+2+Trial+of+BACE+Inhibitor+Due+to+Liver+Toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%2BRogers%26aufirst%3DM.%26jtitle%3DLilly%2520Halts%2520Phase%25202%2520Trial%2520of%2520BACE%2520Inhibitor%2520Due%2520to%2520Liver%2520Toxicity%26pub%3DAlzforum%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard-Cofield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krejsa, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeline, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hougham, C.</span></span> <span> </span><span class="NLM_article-title">High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1007/s00204-006-0091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1007%2Fs00204-006-0091-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=16598496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVynurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=580-604&author=P.+J.+O%E2%80%99Brienauthor=W.+Irwinauthor=D.+Diazauthor=E.+Howard-Cofieldauthor=C.+M.+Krejsaauthor=M.+R.+Slaughterauthor=B.+Gaoauthor=N.+Kaludercicauthor=A.+Angelineauthor=P.+Bernardiauthor=P.+Brainauthor=C.+Hougham&title=High+concordance+of+drug-induced+human+hepatotoxicity+with+in+vitro+cytotoxicity+measured+in+a+novel+cell-based+model+using+high+content+screening&doi=10.1007%2Fs00204-006-0091-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening</span></div><div class="casAuthors">O'Brien, P. J.; Irwin, W.; Diaz, D.; Howard-Cofield, E.; Krejsa, C. M.; Slaughter, M. R.; Gao, B.; Kaludercic, N.; Angeline, A.; Bernardi, P.; Brain, P.; Hougham, C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">580-604</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To develop and validate a practical, in vitro, cell-based model to assess human hepatotoxicity potential of drugs, we used the new technol. of high content screening (HCS) and a novel combination of crit. model features, including (1) use of live, human hepatocytes with drug metab. capability, (2) preincubation of cells for 3 days with drugs at a range of concns. up to at least 30 times the efficacious concn. or 100 μM, (3) measurement of multiple parameters that were (4) morphol. and biochem., (5) indicative of prelethal cytotoxic effects, (6) representative of different mechanisms of toxicity, (7) at the single cell level and (8) amenable to rapid throughput.  HCS is based on automated epifluorescence microscopy and image anal. of cells in a microtiter plate format.  The assay was applied to HepG2 human hepatocytes cultured in 96-well plates and loaded with four fluorescent dyes for: calcium (Fluo-4 AM), mitochondrial membrane potential (TMRM), DNA content (Hoechst 33342) to det. nuclear area and cell no. and plasma membrane permeability (TOTO-3).  Assay results were compared with those from 7 conventional, in vitro cytotoxicity assays that were applied to 611 compds. and shown to have low sensitivity (<25%), although high specificity (∼90%) for detection of toxic drugs.  For 243 drugs with varying degrees of toxicity, the HCS, sublethal, cytotoxicity assay had a sensitivity of 93% and specificity of 98%.  Drugs testing pos. that did not cause hepatotoxicity produced other serious, human organ toxicities.  For 201 pos. assay results, 86% drugs affected cell no., 70% affected nuclear area and mitochondrial membrane potential and 45% affected membrane permeability and 41% intracellular calcium concn.  Cell no. was the first parameter affected for 56% of these drugs, nuclear area for 34% and mitochondrial membrane potential for 29% and membrane permeability for 7% and intracellular calcium for 10%.  Hormesis occurred for 48% of all drugs with pos. response, for 26% of mitochondrial and 34% nuclear area changes and 12% of cell no. changes.  Pattern of change was dependent on the class of drug and mechanism of toxicity.  The ratio of concns. for in vitro cytotoxicity to maximal efficaciousness in humans was not different across groups (12±22).  Human toxicity potential was detected with 80% sensitivity and 90% specificity at a concn. of 30× the maximal efficacious concn. or 100 μM when efficaciousness was not considered.  We conclude that human hepatotoxicity is highly concordant with in vitro cytotoxicity in this novel model and as detected by HCS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroZK_xw9EaJrVg90H21EOLACvtfcHk0lh47a17Qp6tjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVynurc%253D&md5=84df3243f11d3309cf86a2f3f6160533</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00204-006-0091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-006-0091-3%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%2BJ.%26aulast%3DIrwin%26aufirst%3DW.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DHoward-Cofield%26aufirst%3DE.%26aulast%3DKrejsa%26aufirst%3DC.%2BM.%26aulast%3DSlaughter%26aufirst%3DM.%2BR.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DAngeline%26aufirst%3DA.%26aulast%3DBernardi%26aufirst%3DP.%26aulast%3DBrain%26aufirst%3DP.%26aulast%3DHougham%26aufirst%3DC.%26atitle%3DHigh%2520concordance%2520of%2520drug-induced%2520human%2520hepatotoxicity%2520with%2520in%2520vitro%2520cytotoxicity%2520measured%2520in%2520a%2520novel%2520cell-based%2520model%2520using%2520high%2520content%2520screening%26jtitle%3DArch.%2520Toxicol.%26date%3D2006%26volume%3D80%26spage%3D580%26epage%3D604%26doi%3D10.1007%2Fs00204-006-0091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance</span>. <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1007/BF01059688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1007%2FBF01059688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=599411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADyaE1cXhtFGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1977&pages=625-653&author=K.+S.+Pangauthor=M.+Rowland&title=Hepatic+clearance+of+drugs.+I.+Theoretical+considerations+of+a+%E2%80%9Cwell-stirred%E2%80%9D+model+and+a+%E2%80%9Cparallel+tube%E2%80%9D+model.+Influence+of+hepatic+blood+flow%2C+plasma+and+blood+cell+binding%2C+and+the+hepatocellular+enzymatic+activity+on+hepatic+drug+clearance&doi=10.1007%2FBF01059688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic clearance of drugs.  I.  Theoretical considerations of a "well-stirred" model and a "parallel tube" model.  Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance</span></div><div class="casAuthors">Pang, K. Sandy; Rowland, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">625-53</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">Two commonly used models of hepatic drug clearance were examd.  The well-stirred model (model I) views the liver as a well-stirred compartment with concn. of drug in the liver in equil. with that in the emergent blood.  The parallel tube model (model II) regards the liver as a series of parallel tubes with enzymes distributed evenly around the tubes and the concn. of drug declining along the length of the tube.  Both models were examd. under steady-state considerations in the absence of diffusional limitations (i.e., cell membranes not limiting the movement of drug mols.).  Equations involving the determinants of hepatic drug clearance (hepatic blood flow, fraction of drug in blood unbound, and the hepatocellular enzymic activity) and various pharmacokinetic parameters were derived.  Similarities and differences between the models were explored.  Although both models predict similar hepatic drug clearances under a variety of conditions, marked differences between them become apparent in their predictions of the influence of changes in the determinants of drug clearance on various pharmacokinetic parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpZaENZqfCbVg90H21EOLACvtfcHk0ljycow6coCczw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhtFGjtLs%253D&md5=6a9e9bf46d9ce3571d8da77495cc9e19</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2FBF01059688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01059688%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DK.%2BS.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DHepatic%2520clearance%2520of%2520drugs.%2520I.%2520Theoretical%2520considerations%2520of%2520a%2520%25E2%2580%259Cwell-stirred%25E2%2580%259D%2520model%2520and%2520a%2520%25E2%2580%259Cparallel%2520tube%25E2%2580%259D%2520model.%2520Influence%2520of%2520hepatic%2520blood%2520flow%252C%2520plasma%2520and%2520blood%2520cell%2520binding%252C%2520and%2520the%2520hepatocellular%2520enzymatic%2520activity%2520on%2520hepatic%2520drug%2520clearance%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1977%26volume%3D5%26spage%3D625%26epage%3D653%26doi%3D10.1007%2FBF01059688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0ljycow6coCczw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0ljycow6coCczw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attalla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span> <span> </span><span class="NLM_article-title">Reversible and species-specific depigmentation effects of AZD3293, a BACE inhibitor for the treatment of Alzheimer’s disease, are related to BACE2 inhibition and confined to epidermis and hair</span>. <i>J. Prev. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.14283/jpad.2016.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.14283%2Fjpad.2016.119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=201-218&author=G.+Cebersauthor=T.+Lejeuneauthor=B.+Attallaauthor=M.+Soderbergauthor=R.+C.+Alexanderauthor=S.+Budd+Haeberleinauthor=A.+R.+Kuglerauthor=E.+W.+Ingersollauthor=S.+Platzauthor=C.+W.+Scott&title=Reversible+and+species-specific+depigmentation+effects+of+AZD3293%2C+a+BACE+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+are+related+to+BACE2+inhibition+and+confined+to+epidermis+and+hair&doi=10.14283%2Fjpad.2016.119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.14283%2Fjpad.2016.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14283%252Fjpad.2016.119%26sid%3Dliteratum%253Aachs%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DLejeune%26aufirst%3DT.%26aulast%3DAttalla%26aufirst%3DB.%26aulast%3DSoderberg%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DIngersoll%26aufirst%3DE.%2BW.%26aulast%3DPlatz%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26atitle%3DReversible%2520and%2520species-specific%2520depigmentation%2520effects%2520of%2520AZD3293%252C%2520a%2520BACE%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520are%2520related%2520to%2520BACE2%2520inhibition%2520and%2520confined%2520to%2520epidermis%2520and%2520hair%26jtitle%3DJ.%2520Prev.%2520Alzheimers%2520Dis.%26date%3D2016%26volume%3D3%26spage%3D201%26epage%3D218%26doi%3D10.14283%2Fjpad.2016.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maron, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Detection and classification of mutagens: a set of base-specific Salmonella tester strains</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">11606</span>– <span class="NLM_lpage">11610</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.24.11606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1073%2Fpnas.91.24.11606" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=11606-11610&author=P.+Geeauthor=D.+M.+Maronauthor=B.+N.+Ames&title=Detection+and+classification+of+mutagens%3A+a+set+of+base-specific+Salmonella+tester+strains&doi=10.1073%2Fpnas.91.24.11606"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.24.11606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.24.11606%26sid%3Dliteratum%253Aachs%26aulast%3DGee%26aufirst%3DP.%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DDetection%2520and%2520classification%2520of%2520mutagens%253A%2520a%2520set%2520of%2520base-specific%2520Salmonella%2520tester%2520strains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D11606%26epage%3D11610%26doi%3D10.1073%2Fpnas.91.24.11606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mesens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steemans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheyen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanparys, P.</span></span> <span> </span><span class="NLM_article-title">A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase</span>. <i>Toxicol. in Vitro</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2008.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2Fj.tiv.2008.11.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=217-226&author=N.+Mesensauthor=M.+Steemansauthor=E.+Hansenauthor=A.+Petersauthor=G.+Verheyenauthor=P.+Vanparys&title=A+96-well+flow+cytometric+screening+assay+for+detecting+in+vitro+phospholipidosis-induction+in+the+drug+discovery+phase&doi=10.1016%2Fj.tiv.2008.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2008.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2008.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DMesens%26aufirst%3DN.%26aulast%3DSteemans%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DE.%26aulast%3DPeters%26aufirst%3DA.%26aulast%3DVerheyen%26aufirst%3DG.%26aulast%3DVanparys%26aufirst%3DP.%26atitle%3DA%252096-well%2520flow%2520cytometric%2520screening%2520assay%2520for%2520detecting%2520in%2520vitro%2520phospholipidosis-induction%2520in%2520the%2520drug%2520discovery%2520phase%26jtitle%3DToxicol.%2520in%2520Vitro%26date%3D2009%26volume%3D23%26spage%3D217%26epage%3D226%26doi%3D10.1016%2Fj.tiv.2008.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ploemen, J.-P. H. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Sandt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Burgsteden, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salemink, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van
Esch, E.</span></span> <span> </span><span class="NLM_article-title">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span>. <i>Exp. Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1078/0940-2993-00338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1078%2F0940-2993-00338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=15088636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=347-355&author=J.-P.+H.+T.+M.+Ploemenauthor=J.+Kelderauthor=T.+Hafmansauthor=H.+Van+de+Sandtauthor=J.+A.+Van+Burgstedenauthor=P.+J.+M.+Saleminkauthor=E.+Van%0AEsch&title=Use+of+physicochemical+calculation+of+pKa+and+CLogP+to+predict+phospholipidosis-inducing+potential%3A+a+case+study+with+structurally+related+piperazines&doi=10.1078%2F0940-2993-00338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span></div><div class="casAuthors">Ploemen, Jan-Peter H. T. M.; Kelder, Jan; Hafmans, Theo; van de Sandt, Han; van Burgsteden, Johan A.; Salemink, Paul J. M.; van Esch, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-355</span>CODEN:
                <span class="NLM_cas:coden">ETPAEK</span>;
        ISSN:<span class="NLM_cas:issn">0940-2993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Several cationic amphiphilic compds. are known to induce phospholipidosis, a condition primarily characterized by excessive accumulation of phospholipids in different cell types, giving the affected cells a finely foamy appearance.  Excessive storage of lamellar membranous intralysosomal inclusion bodies is the hallmark for phospholipidosis on the electron microscopic level.  In case of alveolar phospholipidosis, foamy macrophages accumulate within the alveolar spaces of the lung.  Based on such findings in a one-year toxicity study with gepirone in rats, we studied the mol. properties of this compd. and compds. suspected of being phospholipidosis inducers by means of physicochem. calcns.  Physicochem. mol. calcns. of mol. wt., ClogP (partition coeff. octanol/water), logD at pH 7.4, and pKa were performed, for the cationic amphiphilic compds. chlorpromazine, amiodarone, imipramine, propranolol and fluoxetine, and for the structurally related compds. 1-phenylpiperazine (1-PHP), gepirone (and its major metabolites, 3-OH-gepirone and 1-pyrimidinylpiperazine [1-PP]), and buspirone.  ClogP and calcd. pKa cluster differently for the amphiphilic drugs compared to the chem. series of piperazines.  In line with this anal., lamellar inclusion bodies were found in an in vitro validation expt. in the human monoblastoid cell line U-937, incubated for 96 h at 10 μg/mL with cationic amphiphilic drugs (amiodarone, imipramine, or propranolol).  No such lamellar inclusion bodies were seen for any of the compds. from the chem. series of piperazines including gepirone and its metabolites.  The data presented support the use of simple physicochem. calcns. of ClogP and pKa to discriminate rapidly between compds. suspected of being phospholipidosis inducers.  Finally, the discriminative power of these physicochem. ClogP and pKa calcns. to predict phospholipidosis-inducing potential was further validated by extension of the set of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-qnA3_zghvbVg90H21EOLACvtfcHk0lg9KKGs7puUUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D&md5=caf5e68d3d5356dfef1cc29dbaf5ca87</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1078%2F0940-2993-00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1078%252F0940-2993-00338%26sid%3Dliteratum%253Aachs%26aulast%3DPloemen%26aufirst%3DJ.-P.%2BH.%2BT.%2BM.%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DHafmans%26aufirst%3DT.%26aulast%3DVan%2Bde%2BSandt%26aufirst%3DH.%26aulast%3DVan%2BBurgsteden%26aufirst%3DJ.%2BA.%26aulast%3DSalemink%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DVan%2BEsch%26aufirst%3DE.%26atitle%3DUse%2520of%2520physicochemical%2520calculation%2520of%2520pKa%2520and%2520CLogP%2520to%2520predict%2520phospholipidosis-inducing%2520potential%253A%2520a%2520case%2520study%2520with%2520structurally%2520related%2520piperazines%26jtitle%3DExp.%2520Toxicol.%2520Pathol.%26date%3D2004%26volume%3D55%26spage%3D347%26epage%3D355%26doi%3D10.1078%2F0940-2993-00338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hanumegowda, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regueiro-Ren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yordanova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corradi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S. P.</span></span> <span> </span><span class="NLM_article-title">Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1021/tx9003825</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx9003825" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVeqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=749-755&author=U.+M.+Hanumegowdaauthor=G.+Wenkeauthor=A.+Regueiro-Renauthor=R.+Yordanovaauthor=J.+P.+Corradiauthor=S.+P.+Adams&title=Phospholipidosis+as+a+function+of+basicity%2C+lipophilicity%2C+and+volume+of+distribution+of+compounds&doi=10.1021%2Ftx9003825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds</span></div><div class="casAuthors">Hanumegowda, Umesh M.; Wenke, Gottfried; Regueiro-Ren, Alicia; Yordanova, Roumyana; Corradi, John P.; Adams, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced phospholipidosis (PLD) is an adaptive histol. alteration that is seen with various marketed drugs and often encountered during drug development.  Various in silico and in vitro cell-based methods have been developed to predict the PLD-inducing potential of compds.  These methods rely on the inherent physicochem. properties of the mol. and, as such, tend to overpredict compds. as PLD inducers.  Recognizing that the distribution of compds. into tissues or tissue accumulation is likely a key factor in PLD induction, in addn. to key physicochem. properties, we developed a model to predict PLD in vivo using the measures of basicity (pKa), lipophilicity (ClogP), and vol. of distribution (Vd).  Using sets of PLD inducers and noninducers, we demonstrate improved concordance with this method.  Furthermore, we propose a screening paradigm that includes a combination of various methods to predict the in vivo PLD-inducing potential of compds., which may be esp. useful in lead identification and optimization processes in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJNq2nVkAysrVg90H21EOLACvtfcHk0lg9KKGs7puUUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVeqtLw%253D&md5=471380f65644ba0db549660acf6b4d8d</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Ftx9003825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9003825%26sid%3Dliteratum%253Aachs%26aulast%3DHanumegowda%26aufirst%3DU.%2BM.%26aulast%3DWenke%26aufirst%3DG.%26aulast%3DRegueiro-Ren%26aufirst%3DA.%26aulast%3DYordanova%26aufirst%3DR.%26aulast%3DCorradi%26aufirst%3DJ.%2BP.%26aulast%3DAdams%26aufirst%3DS.%2BP.%26atitle%3DPhospholipidosis%2520as%2520a%2520function%2520of%2520basicity%252C%2520lipophilicity%252C%2520and%2520volume%2520of%2520distribution%2520of%2520compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2010%26volume%3D23%26spage%3D749%26epage%3D755%26doi%3D10.1021%2Ftx9003825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tréton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, A.</span></span> <span> </span><span class="NLM_article-title">Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer’s disease</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01207.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1111%2Fj.1476-5381.2011.01207.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=21232036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1GitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=375-389&author=B.+Van%0ABroeckauthor=J.-M.+Chenauthor=G.+Tr%C3%A9tonauthor=M.+Desmidtauthor=C.+Hopfauthor=N.+Ramsdenauthor=E.+Karranauthor=M.+Merckenauthor=A.+Rowley&title=Chronic+treatment+with+a+novel+%CE%B3-secretase+modulator%2C+JNJ-40418677%2C+inhibits+amyloid+plaque+formation+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1476-5381.2011.01207.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Van Broeck, B.; Chen, J.-M.; Treton, G.; Desmidt, M.; Hopf, C.; Ramsden, N.; Karran, E.; Mercken, M.; Rowley, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-389</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">γ-Secretase modulators represent a promising therapeutic approach for Alzheimer's disease (AD) because they selectively decrease amyloid β 42 (Aβ42), a particularly neurotoxic Aβ species that accumulates in plaques in the brains of patients with AD.  In the present study, we describe the in vitro and in vivo pharmacol. properties of a potent novel γ-secretase modulator, 2-(S)-(3,5-bis(4-(trifluoromethyl)phenyl)phenyl)-4-methylpentanoic acid (JNJ-40418677).  The potency and selectivity of JNJ-40418677 for Aβ redn. was investigated in human neuroblastoma cells, rat primary neurons and after treatment with single oral doses in non-transgenic mouse brains.  To evaluate the effect of JNJ-40418677 on plaque formation, Tg2576 mice were treated from 6 until 13 mo of age via the diet.  JNJ-40418677 selectively reduced Aβ42 secretion in human neuroblastoma cells and rat primary neurons, but it did not inhibit Notch processing or formation of other amyloid precursor protein cleavage products.  Oral treatment of non-transgenic mice with JNJ-40418677 resulted in an excellent brain penetration of the compd. and a dose- and time-dependent decrease of brain Aβ42 levels.  Chronic treatment of Tg2576 mice with JNJ-40418677 reduced brain Aβ levels, the area occupied by plaques and plaque no. in a dose-dependent manner compared with transgenic vehicle-treated mice.  JNJ-40418677 selectively decreased Aβ42 prodn., showed an excellent brain penetration after oral administration in mice and lowered brain Aβ burden in Tg2576 mice after chronic treatment.  JNJ-40418677 therefore warrants further investigation as a potentially effective disease-modifying therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MGWYryyTFbVg90H21EOLACvtfcHk0lgG01U9Js7iCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1GitL0%253D&md5=aae5e894472fc12258ef3e4662a726e4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01207.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01207.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DJ.-M.%26aulast%3DTr%25C3%25A9ton%26aufirst%3DG.%26aulast%3DDesmidt%26aufirst%3DM.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DA.%26atitle%3DChronic%2520treatment%2520with%2520a%2520novel%2520%25CE%25B3-secretase%2520modulator%252C%2520JNJ-40418677%252C%2520inhibits%2520amyloid%2520plaque%2520formation%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26spage%3D375%26epage%3D389%26doi%3D10.1111%2Fj.1476-5381.2011.01207.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Heinrich Rueeger, Rainer Lueoend, Rainer Machauer, Siem J. Veenstra, Philipp Holzer, Konstanze Hurth, Markus Voegtle, Mathias Frederiksen, Jean-Michel Rondeau, Marina Tintelnot-Blomley, Laura H. Jacobson, Matthias Staufenbiel, Grit Laue, <span class="NLM_string-name hlFld-ContribAuthor">Ulf Neumann</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4677-4696. <a href="https://doi.org/10.1021/acs.jmedchem.0c02143" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bthe%252BPotent%25252C%252BSelective%25252C%252Band%252BEfficacious%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitor%252BNB-360%26aulast%3DRueeger%26aufirst%3DHeinrich%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D11122020%26date%3D12042021%26volume%3D64%26issue%3D8%26spage%3D4677%26epage%3D4696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elena Lenci, Lorenzo Calugi, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Trabocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Occurrence of Morpholine in Central Nervous System Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 378-390. <a href="https://doi.org/10.1021/acschemneuro.0c00729" title="DOI URL">https://doi.org/10.1021/acschemneuro.0c00729</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.0c00729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.0c00729%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DOccurrence%252Bof%252BMorpholine%252Bin%252BCentral%252BNervous%252BSystem%252BDrug%252BDiscovery%26aulast%3DLenci%26aufirst%3DElena%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13112020%26date%3D11012021%26date%3D18012021%26volume%3D12%26issue%3D3%26spage%3D378%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhiwei Chen, Xiang Bai, Jie Sun, <span class="NLM_string-name hlFld-ContribAuthor">Yicheng Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Fe(III)-Catalyzed Decarboxylative C3-Difluoroarylmethylation of Coumarins with α,α-Difluoroarylacetic Acids. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (12)
                                     , 7674-7682. <a href="https://doi.org/10.1021/acs.joc.0c00113" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00113%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFe%252528III%252529-Catalyzed%252BDecarboxylative%252BC3-Difluoroarylmethylation%252Bof%252BCoumarins%252Bwith%252B%2525CE%2525B1%25252C%2525CE%2525B1-Difluoroarylacetic%252BAcids%26aulast%3DChen%26aufirst%3DZhiwei%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15012020%26date%3D04062020%26date%3D21052020%26volume%3D85%26issue%3D12%26spage%3D7674%26epage%3D7682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Genta Tadano, Kazuo Komano, Shuhei Yoshida, Shinji Suzuki, Kenji Nakahara, Kouki Fuchino, Kazuki Fujimoto, Eriko Matsuoka, Takahiko Yamamoto, Naoya Asada, Hisanori Ito, Gaku Sakaguchi, Naoki Kanegawa, Yasuto Kido, Shigeru Ando, Tamio Fukushima, Ard Teisman, Vijay Urmaliya, Deborah Dhuyvetter, Herman Borghys, An Van Den Bergh, Nigel Austin, Harrie J. M. Gijsen, Yoshinori Yamano, Yasuyoshi Iso, <span class="NLM_string-name hlFld-ContribAuthor">Ken-ichi Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of an Extremely Potent Thiazine-Based β-Secretase Inhibitor with Reduced Cardiovascular and Liver Toxicity at a Low Projected Human Dose. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9331-9337. <a href="https://doi.org/10.1021/acs.jmedchem.9b01140" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01140%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ban%252BExtremely%252BPotent%252BThiazine-Based%252B%2525CE%2525B2-Secretase%252BInhibitor%252Bwith%252BReduced%252BCardiovascular%252Band%252BLiver%252BToxicity%252Bat%252Ba%252BLow%252BProjected%252BHuman%252BDose%26aulast%3DTadano%26aufirst%3DGenta%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14072019%26date%3D08102019%26date%3D24092019%26volume%3D62%26issue%3D20%26spage%3D9331%26epage%3D9337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Daniel Oehlrich, Aldo Peschiulli, Gary Tresadern, Michiel Van Gool, Juan Antonio Vega, Ana Isabel De Lucas, Sergio A. Alonso de Diego, Hana Prokopcova, Nigel Austin, Sven Van Brandt, Michel Surkyn, Michel De Cleyn, Ann Vos, Frederik J. R. Rombouts, Gregor Macdonald, Dieder Moechars, Harrie J. M. Gijsen, <span class="NLM_string-name hlFld-ContribAuthor">Andrés A. Trabanco</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine Warheads. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1159-1165. <a href="https://doi.org/10.1021/acsmedchemlett.9b00181" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00181%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEvaluation%252Bof%252Ba%252BSeries%252Bof%252B%2525CE%2525B2-Secretase%252B1%252BInhibitors%252BContaining%252BNovel%252BHeteroaryl-Fused-Piperazine%252BAmidine%252BWarheads%26aulast%3DOehlrich%26aufirst%3DDaniel%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19042019%26date%3D02072019%26date%3D05072019%26date%3D02072019%26volume%3D10%26issue%3D8%26spage%3D1159%26epage%3D1165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Harrie J. M.    Gijsen </span><span class="hlFld-ContribAuthor "> Jinguang    Lin </span><span class="hlFld-ContribAuthor "> Yannis    Houpis </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Chemical Development of JNJ-50138803, a Clinical Candidate BACE1 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 91-114. <a href="https://doi.org/10.1021/bk-2018-1307.ch004" title="DOI URL">https://doi.org/10.1021/bk-2018-1307.ch004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2018-1307.ch004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2018-1307.ch004%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BChemical%252BDevelopment%252Bof%252BJNJ-50138803%25252C%252Ba%252BClinical%252BCandidate%252BBACE1%252BInhibitor%26aulast%3DGijsen%26aufirst%3DHarrie%2BJ.%2BM.%26date%3D2018%26date%3D2018%26spage%3D91%26epage%3D114%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B1%26aulast%3DAbdel-Magid%26aufirst%3DAhmed%2BF.%26date%3D2018%26date%3D2018%26volume%3D1307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aldo  Peschiulli</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ann  Vos</span>, <span class="hlFld-ContribAuthor ">Harrie JM  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (8)
                                     , 126999. <a href="https://doi.org/10.1016/j.bmcl.2020.126999" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126999%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3%25252C3-Difluoro-3%25252C4%25252C5%25252C6-tetrahydropyridin-2-amines%25253A%252BPotent%252Band%252Bpermeable%252BBACE-1%252Binhibitors%26aulast%3DPeschiulli%26aufirst%3DAldo%26date%3D2020%26volume%3D30%26issue%3D8%26spage%3D126999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You-Chen  Lin</span>, <span class="hlFld-ContribAuthor ">Christina  Martinez-Brokaw</span>, <span class="hlFld-ContribAuthor ">Joshua G.  Pierce</span>. </span><span class="cited-content_cbyCitation_article-title">1,4-Oxazines and Their Benzo Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00036-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00036-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00036-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00036-6%26sid%3Dliteratum%253Aachs%26atitle%3D1%25252C4-Oxazines%252Band%252BTheir%252BBenzo%252BDerivatives%26aulast%3DLin%26aufirst%3DYou-Chen%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhafer S.  Zinad</span>, <span class="hlFld-ContribAuthor ">Ahmed  Mahal</span>, <span class="hlFld-ContribAuthor ">Ranjan K.  Mohapatra</span>, <span class="hlFld-ContribAuthor ">Ashish K.  Sarangi</span>, <span class="hlFld-ContribAuthor ">Mohammad Rizki Fadhil  Pratama</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry of oxazines as promising agents in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (1)
                                     , 16-47. <a href="https://doi.org/10.1111/cbdd.13633" title="DOI URL">https://doi.org/10.1111/cbdd.13633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13633%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DMedicinal%252Bchemistry%252Bof%252Boxazines%252Bas%252Bpromising%252Bagents%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZinad%26aufirst%3DDhafer%2BS.%26date%3D2020%26date%3D2019%26volume%3D95%26issue%3D1%26spage%3D16%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Different generations of 1,4-oxazine BACE1 inhibitors, improving P-gp efflux and the cardiovascular safety profile.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 2-CF<sub>3</sub>–1-4-Oxazines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) TMSCF<sub>3</sub>, TBAT, THF, 0 °C to rt, 20 min; (b) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (c) Zn, AcOH, 100 °C, 20 min; (d) P<sub>2</sub>S<sub>5</sub>, THF, 70 °C, 2–4 h; (e) 7N NH<sub>3</sub> in MeOH, 80 °C, 2 h; (f) NaN<sub>3</sub>, CuI, DMEDA, Na<sub>2</sub>CO<sub>3</sub>, DMSO, 110 °C, 4h; (g) RCOOH, DMTMM, MeOH, 0 °C to rt, 2–24 h; (h) 5-pyrimidinylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub> satd aq, 1,4-dioxane, 80 °C, 2 h; (i) (<i>E</i>)-(2-(5-cyanopyridin-2-yl)vinyl)boronic acid pinacol ester, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub> satd aq, 1,4-dioxane, 140 °C, 0.5 h, μw; (j) 2-bromo-3-cyanopyridine, dppf, Pd<sub>2</sub>(dba)<sub>3</sub>, Cs<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, 160 °C, 1 h, μw. Compound <b>18</b> was prepared as a racemate, starting from racemic <b><b>15</b></b>.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2-CF<sub>2</sub>- and 2-CHF<sub>2</sub>–1,4-Oxazines<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents: (a) Zn–Cu, AcOH, rt, 16 h; (b) P<sub>2</sub>S<sub>5</sub>, THF, 70 °C, 2–4 h; (c) 7N NH<sub>3</sub> in MeOH, 80 °C, 2 h; (d) NaN<sub>3</sub>, CuI, DMEDA, Na<sub>2</sub>CO<sub>3</sub>, DMSO, 110 °C, 3 h; (e) 5-methoxy-2-pyrazinecarboxylic acid, DMTMM, MeOH, 0 °C, 2–6 h; (f) H<sub>2</sub>, Pd/C, thiophene, EtOAc, rt, 16 h.</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/medium/jm-2018-00304w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Beagle dog plasma levels of <b>3</b> and effect on CSF Aβ42 levels on day 1 and 6 after repeated oral dosing (fasted state, once daily dosing). Avg + SEM, <i>n</i> = 6/dose group (MS: MesoScale).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-12/acs.jmedchem.8b00304/20180622/images/large/jm-2018-00304w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00304&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 21 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <i>World Alzheimer
Report 2016</i>; <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2016</span>; <a href="https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf" class="extLink">https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf</a> (accessed May 7, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+World+Alzheimer%0AReport+2016%3B+Alzheimer%E2%80%99s+Disease+International%3A+London%2C+2016%3B+https%3A%2F%2Fwww.alz.co.uk%2Fresearch%2FWorldAlzheimerReport2016.pdf+%28accessed+May+7%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Alzheimer%250AReport%25202016%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, O. L.</span></span> <span> </span><span class="NLM_article-title">The growing burden of Alzheimer’s disease</span>. <i>Am. J. Manag. Care</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">S339</span>– <span class="NLM_lpage">S345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=22214391" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=S339-S345&author=O.+L.+Lopez&title=The+growing+burden+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLopez%26aufirst%3DO.%2BL.%26atitle%3DThe%2520growing%2520burden%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAm.%2520J.%2520Manag.%2520Care%26date%3D2011%26volume%3D17%26spage%3DS339%26epage%3DS345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Marešová, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohelská, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolejš, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuča, K.</span></span> <span> </span><span class="NLM_article-title">Socio-economic aspects of Alzheimer’s disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">903</span>– <span class="NLM_lpage">911</span>, <span class="refDoi"> DOI: 10.2174/156720501209151019111448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.2174%2F156720501209151019111448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=26510983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGitbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=903-911&author=P.+Mare%C5%A1ov%C3%A1author=H.+Mohelsk%C3%A1author=J.+Dolej%C5%A1author=K.+Ku%C4%8Da&title=Socio-economic+aspects+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F156720501209151019111448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">Socio-economic Aspects of Alzheimer's Disease</span></div><div class="casAuthors">Maresova, Petra; Mohelska, Hana; Dolejs, Josef; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">903-911</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Social development, better living conditions and medical advances lead to the fact that more people have the opportunity to live longer than in the past.  The aging population is a characteristic feature of demog. trends in developed countries.  This trend is closely linked with the issue of increasing no. of diseases in old age and increasing government expenditure on health and social care.  The most frequently mentioned diseases in old age include dementia.  The cause may lie in all kinds of diseases, the most common are Alzheimer's disease and cerebrovascular disease.  Now the care of current 35 million patients with dementia costs over $ 600 billion per yr, it is approx. one percent of global Gross Domestic Product.  This review discusses the recent issues and questions in the area of social and economic aspects of Alzheimer's disease.  It focuses in detail on the national strategies in the approach to Alzheimer's disease, the anticipated problems concerning the insufficient no. of social workers and necessary expenses of state budgets in the future.  The situation in the area of health insurance companies' expenditures is illustrated in the context of the anal. of long-term care systems, in the chosen countries within the European Union.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoiq1ROmJCe7Vg90H21EOLACvtfcHk0lixYLlMtxFmFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGitbvO&md5=625e48233fdd8829da1631aa173fcf8d</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.2174%2F156720501209151019111448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720501209151019111448%26sid%3Dliteratum%253Aachs%26aulast%3DMare%25C5%25A1ov%25C3%25A1%26aufirst%3DP.%26aulast%3DMohelsk%25C3%25A1%26aufirst%3DH.%26aulast%3DDolej%25C5%25A1%26aufirst%3DJ.%26aulast%3DKu%25C4%258Da%26aufirst%3DK.%26atitle%3DSocio-economic%2520aspects%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2015%26volume%3D12%26spage%3D903%26epage%3D911%26doi%3D10.2174%2F156720501209151019111448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Green, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span> <span> </span><span class="NLM_article-title">Advances in Our Understanding of the Pathophysiology of Alzheimer’s Disease</span>. <i>US Neurology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.17925/USN.2010.06.01.28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.17925%2FUSN.2010.06.01.28" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=28-31&author=K.+N.+Greenauthor=S.+Schreiber&title=Advances+in+Our+Understanding+of+the+Pathophysiology+of+Alzheimer%E2%80%99s+Disease&doi=10.17925%2FUSN.2010.06.01.28"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.17925%2FUSN.2010.06.01.28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.17925%252FUSN.2010.06.01.28%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DK.%2BN.%26aulast%3DSchreiber%26aufirst%3DS.%26atitle%3DAdvances%2520in%2520Our%2520Understanding%2520of%2520the%2520Pathophysiology%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DUS%2520Neurology%26date%3D2010%26volume%3D6%26spage%3D28%26epage%3D31%26doi%3D10.17925%2FUSN.2010.06.01.28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Swerdlow, R. H.</span></span> <span> </span><span class="NLM_article-title">Pathogenesis of Alzheimer’s disease</span>. <i>Clin. Interv. Aging</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=18044185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlOltbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=347-359&author=R.+H.+Swerdlow&title=Pathogenesis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of Alzheimer's disease</span></div><div class="casAuthors">Swerdlow, Russell H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Interventions in Aging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-359</span>CODEN:
                <span class="NLM_cas:coden">CIALBC</span>;
        ISSN:<span class="NLM_cas:issn">1176-9092</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press (NZ) Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is incredibly common.  Increasing longevity ensures its prevalence will rise even further.  Ongoing efforts to understand AD pathogenesis reveal numerous tantalizing leads.  Formulating a comprehensive AD pathogenesis theory capable of incorporating these disparate leads, though, has proven difficult.  This review discusses current attempts to formulate a comprehensive AD pathogenesis theory.  In doing so, it focuses on clin. and mol. relationships between AD and aging.  A better understanding of these relationships could inform and impact future development of AD-directed treatment strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDTJfub3KthrVg90H21EOLACvtfcHk0lixYLlMtxFmFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlOltbrF&md5=44564cf07c3c020d4feb627f64654d86</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwerdlow%26aufirst%3DR.%2BH.%26atitle%3DPathogenesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DClin.%2520Interv.%2520Aging%26date%3D2007%26volume%3D2%26spage%3D347%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: the amyloid cascade hypothesis</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1126/science.1566067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1126%2Fscience.1566067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1566067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=1992&pages=184-185&author=J.+A.+Hardyauthor=G.+A.+Higgins&title=Alzheimer%E2%80%99s+disease%3A+the+amyloid+cascade+hypothesis&doi=10.1126%2Fscience.1566067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease:  the amyloid cascade hypothesis</span></div><div class="casAuthors">Hardy, John A.; Higgins, Gerald A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue">5054</span>),
    <span class="NLM_cas:pages">184-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A review with 28 refs.  The hypotheses that deposition of amyloid β protein (AβP), the main component of the plaques, is the causative agent of Alzheimer's pathol. and that the neurofibrillary tangles, cell loss, vascular damage, and dementia follow as a direct result of this deposition are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqemkoU65i2CrVg90H21EOLACvtfcHk0lgf3AIUFldMJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xitlarurg%253D&md5=0ad307ce9ecab261ed7b01e6d288682a</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1566067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1566067%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520the%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DScience%26date%3D1992%26volume%3D256%26spage%3D184%26epage%3D185%26doi%3D10.1126%2Fscience.1566067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selkoe, D. J.</span></span> <span> </span><span class="NLM_article-title">The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>297</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+A.+Hardyauthor=D.+J.+Selkoe&title=The+amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lhoXquJ5oj14w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%2BA.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span> <span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0lgq_M5mtgJ5Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vassar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haass, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendran, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichtenthaler, S. F.</span></span> <span> </span><span class="NLM_article-title">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">28</span>, <span class="refDoi"> DOI: 10.1111/jnc.12715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1111%2Fjnc.12715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=24646365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=4-28&author=R.+Vassarauthor=P.-H.+Kuhnauthor=C.+Haassauthor=M.+E.+Kennedyauthor=L.+Rajendranauthor=P.+C.+Wongauthor=S.+F.+Lichtenthaler&title=Function%2C+therapeutic+potential+and+cell+biology+of+BACE+proteases%3A+current+status+and+future+prospects&doi=10.1111%2Fjnc.12715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span></div><div class="casAuthors">Vassar, Robert; Kuhn, Peer-Hendrik; Haass, Christian; Kennedy, Matthew E.; Rajendran, Lawrence; Wong, Philip C.; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-28</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The β-site APP cleaving enzymes 1 and 2 (BACE1 and BACE2) were initially identified as transmembrane aspartyl proteases cleaving the amyloid precursor protein (APP).  BACE1 is a major drug target for Alzheimer's disease because BACE1-mediated cleavage of APP is the first step in the generation of the pathogenic amyloid-β peptides.  BACE1, which is highly expressed in the nervous system, is also required for myelination by cleaving neuregulin 1.  Several recent proteomic and in vivo studies using BACE1- and BACE2-deficient mice demonstrate a much wider range of physiol. substrates and functions for both proteases within and outside of the nervous system.  For BACE1 this includes axon guidance, neurogenesis, muscle spindle formation, and neuronal network functions, whereas BACE2 was shown to be involved in pigmentation and pancreatic β-cell function.  This review highlights the recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer's disease.  The protease BACE1 is a major drug target in Alzheimer disease.  Together with its homolog BACE2, both proteases have an increasing no. of functions within and outside of the nervous system.  This review highlights recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxkCRjc9dYMLVg90H21EOLACvtfcHk0ljG__mXiF4_Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M&md5=79e394bb720ad6639f8efc86138fcd60</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12715%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKuhn%26aufirst%3DP.-H.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DRajendran%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%26atitle%3DFunction%252C%2520therapeutic%2520potential%2520and%2520cell%2520biology%2520of%2520BACE%2520proteases%253A%2520current%2520status%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D130%26spage%3D4%26epage%3D28%26doi%3D10.1111%2Fjnc.12715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Hall, A.</span>; <span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">Targeting β-secretase (BACE) for the treatment of Alzheimer’s disease</span>, In  <i>Comprehensive Medicinal Chemistry III</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span>, <span class="NLM_string-name">Rotella, D.</span>, <span class="NLM_string-name">Ward, S. E.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Oxford</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">326</span>– <span class="NLM_lpage">383</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2FB978-0-12-409547-2.13809-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=326-383&author=A.+Hall&author=H.+J.+M.+Gijsenauthor=S.+Chackalamannil&author=D.+Rotella&author=S.+E.+Ward&title=Comprehensive+Medicinal+Chemistry+III"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DA.%26atitle%3DTargeting%2520%25CE%25B2-secretase%2520%2528BACE%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26btitle%3DComprehensive%2520Medicinal%2520Chemistry%2520III%26aulast%3DChackalamannil%26aufirst%3DS.%26pub%3DElsevier%26date%3D2017%26spage%3D326%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of amidine-based brain penetrant BACE1 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2033</span>– <span class="NLM_lpage">2045</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.03.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-2045&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+M.+Gijsen&title=The+evolution+of+amidine-based+brain+penetrant+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2014.03.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0ljG__mXiF4_Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DThe%2520evolution%2520of%2520amidine-based%2520brain%2520penetrant%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D2045%26doi%3D10.1016%2Fj.bmcl.2014.03.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowman Rogers, M.</span></span> <i>Merck Axes Verubecestat for Prodromal AD, Researchers Say ‘Go Earlier’</i>; <span class="NLM_publisher-name">Alzforum</span>, <span class="NLM_year">2018</span>; <a href="https://www.alzforum.org/news/research-news/merck-axes-verubecestat-prodromal-ad-researchers-say-go-earlier" class="extLink">https://www.alzforum.org/news/research-news/merck-axes-verubecestat-prodromal-ad-researchers-say-go-earlier</a> (accessed May 7, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Bowman+Rogers&title=Merck+Axes+Verubecestat+for+Prodromal+AD%2C+Researchers+Say+%E2%80%98Go+Earlier%E2%80%99"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%2BRogers%26aufirst%3DM.%26jtitle%3DMerck%2520Axes%2520Verubecestat%2520for%2520Prodromal%2520AD%252C%2520Researchers%2520Say%2520%25E2%2580%2598Go%2520Earlier%25E2%2580%2599%26pub%3DAlzforum%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salihoglu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blume, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorostkar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brose, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herms, J.</span></span> <span> </span><span class="NLM_article-title">BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology</span>. <i>Acta Neuropathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1007/s00401-017-1804-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1007%2Fs00401-017-1804-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2018&pages=695-710&author=F.+Petersauthor=H.+Salihogluauthor=E.+Rodriguesauthor=E.+Herzogauthor=T.+Blumeauthor=S.+Filserauthor=M.+Dorostkarauthor=D.+R.+Shimshekauthor=N.+Broseauthor=U.+Neumannauthor=J.+Herms&title=BACE1+inhibition+more+effectively+suppresses+initiation+than+progression+of+%CE%B2-amyloid+pathology&doi=10.1007%2Fs00401-017-1804-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1007%2Fs00401-017-1804-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-017-1804-9%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DF.%26aulast%3DSalihoglu%26aufirst%3DH.%26aulast%3DRodrigues%26aufirst%3DE.%26aulast%3DHerzog%26aufirst%3DE.%26aulast%3DBlume%26aufirst%3DT.%26aulast%3DFilser%26aufirst%3DS.%26aulast%3DDorostkar%26aufirst%3DM.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DBrose%26aufirst%3DN.%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DHerms%26aufirst%3DJ.%26atitle%3DBACE1%2520inhibition%2520more%2520effectively%2520suppresses%2520initiation%2520than%2520progression%2520of%2520%25CE%25B2-amyloid%2520pathology%26jtitle%3DActa%2520Neuropathol.%26date%3D2018%26volume%3D135%26spage%3D695%26epage%3D710%26doi%3D10.1007%2Fs00401-017-1804-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Reiman, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langbaum, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tariot, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopera, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperling, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aisen, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roses, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welsh-Bohmer, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrillo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weninger, S.</span></span> <span> </span><span class="NLM_article-title">CAP – advancing the evaluation of preclinical Alzheimer disease treatments</span>. <i>Nat. Rev. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1038/nrneurol.2015.177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1038%2Fnrneurol.2015.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=26416539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Slt7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=56-61&author=E.+M.+Reimanauthor=J.+B.+Langbaumauthor=P.+N.+Tariotauthor=F.+Loperaauthor=R.+J.+Batemanauthor=J.+C.+Morrisauthor=R.+A.+Sperlingauthor=P.+S.+Aisenauthor=A.+D.+Rosesauthor=K.+A.+Welsh-Bohmerauthor=M.+C.+Carrilloauthor=S.+Weninger&title=CAP+%E2%80%93+advancing+the+evaluation+of+preclinical+Alzheimer+disease+treatments&doi=10.1038%2Fnrneurol.2015.177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">CAP-advancing the evaluation of preclinical Alzheimer disease treatments</span></div><div class="casAuthors">Reiman, Eric M.; Langbaum, Jessica B.; Tariot, Pierre N.; Lopera, Francisco; Bateman, Randall J.; Morris, John C.; Sperling, Reisa A.; Aisen, Paul S.; Roses, Allen D.; Welsh-Bohmer, Kathleen A.; Carrillo, Maria C.; Weninger, Stacie</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-61</span>CODEN:
                <span class="NLM_cas:coden">NRNACP</span>;
        ISSN:<span class="NLM_cas:issn">1759-4758</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  If the authors are to find treatments to postpone, reduce the risk of, or completely prevent the clin. onset of Alzheimer disease (AD), the authors need faster methods to evaluate promising preclin. AD treatments, new ways to work together in support of common goals, and a detn. to expedite the initiation and performance of preclin. AD trials.  In this article, the authors note some of the current challenges, opportunities and emerging strategies in preclin. AD treatment.  The authors describe the Collaboration for Alzheimer's Prevention (CAP)-a convening, harmonizing and consensus-building initiative to help stakeholders advance AD prevention research with rigor, care and maximal impact-and the authors demonstrate the impact of CAP on the goals and design of new preclin. AD trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwWEUYE-RaibVg90H21EOLACvtfcHk0ljKsHnjHAJ6iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Slt7nF&md5=07952464ae96afd026af6cc888c9dcd8</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1038%2Fnrneurol.2015.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrneurol.2015.177%26sid%3Dliteratum%253Aachs%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DLangbaum%26aufirst%3DJ.%2BB.%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DLopera%26aufirst%3DF.%26aulast%3DBateman%26aufirst%3DR.%2BJ.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DRoses%26aufirst%3DA.%2BD.%26aulast%3DWelsh-Bohmer%26aufirst%3DK.%2BA.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DWeninger%26aufirst%3DS.%26atitle%3DCAP%2520%25E2%2580%2593%2520advancing%2520the%2520evaluation%2520of%2520preclinical%2520Alzheimer%2520disease%2520treatments%26jtitle%3DNat.%2520Rev.%2520Neurol.%26date%3D2016%26volume%3D12%26spage%3D56%26epage%3D61%26doi%3D10.1038%2Fnrneurol.2015.177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F. J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tresadern, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delgado, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Lamenca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gool, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Molina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso de
Diego, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehlrich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prokopcova, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Brandt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surkyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Cleyn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdonald, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trabanco, A. A.</span></span> <span> </span><span class="NLM_article-title">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: from hit generation to orally bioavailable brain penetrant leads</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8216</span>– <span class="NLM_lpage">8235</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+R.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de%0ADiegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-Secretase+1+%28BACE1%29+Inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0lh4pE653XcxmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%2BR.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-Secretase%25201%2520%2528BACE1%2529%2520Inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clerck, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van De Water, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Aubioul, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rossem, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Ammel, K.</span></span> <span> </span><span class="NLM_article-title">In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to preclinical cardiovascular safety pharmacology of a new chemical entity</span>. <i>Fundam. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1046/j.1472-8206.2002.00081.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1046%2Fj.1472-8206.2002.00081.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=12031065" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvFOrurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=125-139&author=F.+De%0AClerckauthor=A.+Van+De+Waterauthor=J.+D%E2%80%99Aubioulauthor=H.+R.+Luauthor=K.+van+Rossemauthor=A.+Hermansauthor=K.+Van+Ammel&title=In+vivo+measurement+of+QT+prolongation%2C+dispersion+and+arrhythmogenesis%3A+application+to+preclinical+cardiovascular+safety+pharmacology+of+a+new+chemical+entity&doi=10.1046%2Fj.1472-8206.2002.00081.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: Application to the preclinical cardiovascular safety pharmacology of a new chemical entity</span></div><div class="casAuthors">De Clerck, Fred; Van de Water, Andre; D'Aubioul, Jan; Lu, Hua Rong; van Rossem, Koen; Hermans, An; Van Ammel, Karel</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-140</span>CODEN:
                <span class="NLM_cas:coden">FCPHEZ</span>;
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">A review.  In addn. to in silico and in vitro measurements, cardiac electrophysiol. in exptl. animals plays a decisive role in the selection of a potential "cardio-safe" new chem. entity (NCE).  The present synopsis critically reviews such in vivo techniques in exptl. animals.  In anesthetized guinea-pigs, surface eCG recordings readily identify the typical effects of Class I to IV anti-arrhythmic compds. and of If blockers such as zatebradine on eCG intervals and morphol., but also of non-cardiovascular NCEs affecting cardiac elec. activity via ion channels or neurogenic mechanisms.  QT/RR plots indicate that bradycardia is a dominant effect of IKr blockers (dual modulation by IKr of sinus node activity and ventricular repolarization).  Nevertheless, correction of QT with Bazett's formula usually distinguishes between drug-induced heart rate redn. and real prolongation of ventricular repolarization (QTc).  The anesthetized guinea-pig model thus is a useful tool for first line in vivo testing of an NCE for effects on cardiac electrophysiol., in particular when combined with measurements of drug levels in plasma and heart tissues.  In anesthetized dogs, advanced eCG analyses identify drug-induced effects on atrial and ventricular intervals, on temporal and transmural dispersion of ventricular repolarization and on incidences of early after-depolarizations.  This can be combined with complete hemodynamic, pulmonary and pharmacokinetic analyses in one prepn.  However, compd. doses/plasma levels needed for effects on ventricular repolarization in this model are substantially higher than those identified in guinea-pigs, at least for IKr blocking compds.  Therefore, the authors use this "information-rich" canine model as a second line approach.  In awake, trained and appropriately instrumented dogs, readings of surface eCG in combination with cardio-hemodynamic and behavioral assessments can be performed after the administration of an NCE via the expected therapeutic route, including oral medication.  However, at higher doses the compd. under scrutiny may induce overall behavioral side-effects, related to its primary pharmacol. action, such as gastrokinetic repercussions or CNS-mediated sedation or excitation.  Such primary pharmacol. effects are bound to compromise the evaluation of real drug-induced changes on cardiac electrophysiol., readily identified by resource-friendly setups in smaller animals.  Therefore, the authors use such paradigms as an imperative, final cardiovascular check-up, before a "First in Man" administration of the NCE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbEqHYy5WNvLVg90H21EOLACvtfcHk0lh4pE653XcxmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvFOrurY%253D&md5=b12da3b167ed603fe3239b6285ce0122</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1046%2Fj.1472-8206.2002.00081.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1472-8206.2002.00081.x%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClerck%26aufirst%3DF.%26aulast%3DVan%2BDe%2BWater%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Aubioul%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DH.%2BR.%26aulast%3Dvan%2BRossem%26aufirst%3DK.%26aulast%3DHermans%26aufirst%3DA.%26aulast%3DVan%2BAmmel%26aufirst%3DK.%26atitle%3DIn%2520vivo%2520measurement%2520of%2520QT%2520prolongation%252C%2520dispersion%2520and%2520arrhythmogenesis%253A%2520application%2520to%2520preclinical%2520cardiovascular%2520safety%2520pharmacology%2520of%2520a%2520new%2520chemical%2520entity%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D2002%26volume%3D16%26spage%3D125%26epage%3D139%26doi%3D10.1046%2Fj.1472-8206.2002.00081.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borghys, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dillen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuyvetter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of two different methods for measurement of amyloid-beta peptides in cerebrospinal fluid after BACE1 inhibition in a dog model</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">39</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.3233/JAD-130599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.3233%2FJAD-130599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=23948925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs12mu7zN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=39-48&author=H.+Borghysauthor=T.+Jacobsauthor=B.+Van+Broeckauthor=L.+Dillenauthor=D.+Dhuyvetterauthor=H.+Gijsenauthor=M.+Mercken&title=Comparison+of+two+different+methods+for+measurement+of+amyloid-beta+peptides+in+cerebrospinal+fluid+after+BACE1+inhibition+in+a+dog+model&doi=10.3233%2FJAD-130599"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Two Different Methods for Measurement of Amyloid-β Peptides in Cerebrospinal Fluid after BACE1 Inhibition in a Dog Model</span></div><div class="casAuthors">Borghys, Herman; Jacobs, Tom; Van Broeck, Bianca; Dillen, Lieve; Dhuyvetter, Deborah; Gijsen, Harrie; Mercken, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">39-48</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Beta-secretase is the first cleavage enzyme of amyloid-β protein precursor (AβPP) in the amyloidogenic pathway, leading to the formation of the plaque forming Amyloid-β (Aβ)1-42 peptide.  BACE (beta-site AβPP cleaving enzyme) 1 inhibition is therefore considered to be a promising disease modifying therapy for Alzheimer's disease.  An early assessment of the in vivo activity of BACE inhibitors was done in dogs since AβPP processing is the same as in humans and this species easily enables longitudinal cerebrospinal fluid (CSF) sampling.  Aβ changes in CSF compared to baseline are used to evaluate target engagement of the compds.  Levels of Aβ1-37, Aβ1-38, Aβ1-40, and Aβ1-42 in CSF are measured with immunoassay (Mesoscale electrochemiluminescence technol.) and with an ultra high-performance liq. chromatog. mass spectrometry (UPLC-MS/MS).  Two exptl. BACE inhibitors were evaluated.  With the immunoassay, a dose dependent decrease is obsd. for all four Aβ peptides.  Measurements with the UPLC-MS/MS are in line with the immunoassay for Aβ1-37, Aβ1-38, and Aβ1-40, however, for Aβ1-42, differences are sometimes obsd. when comparing to changes seen in the other peptides with UPLC-MS/MS and with immunoassay results.  Generally lower concns. are measured with immunoassay.  The reason for these differences is still unknown.  Aβ1-42 is more prone to form aggregates compared to the other peptides.  One hypothesis could be that while the immunoassay only measures free Aβ, bound and aggregated Aβ peptides are at least partially dissolved with the UPLC-MS/MS method, since acetonitrile is added to the CSF samples.  This increases variability in the concn. of Aβ peptide measured with UPLC-MS/MS, esp. for Aβ1-42, potentially masking the compd. effect on Aβ1-42 levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_u_w4V1IufLVg90H21EOLACvtfcHk0ljq0yzkR55anQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs12mu7zN&md5=06649719f3ab8f260dda2f62a3ed2c42</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3233%2FJAD-130599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-130599%26sid%3Dliteratum%253Aachs%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DJacobs%26aufirst%3DT.%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DDillen%26aufirst%3DL.%26aulast%3DDhuyvetter%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DMercken%26aufirst%3DM.%26atitle%3DComparison%2520of%2520two%2520different%2520methods%2520for%2520measurement%2520of%2520amyloid-beta%2520peptides%2520in%2520cerebrospinal%2520fluid%2520after%2520BACE1%2520inhibition%2520in%2520a%2520dog%2520model%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D39%26epage%3D48%26doi%3D10.3233%2FJAD-130599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnstone, C.</span></span> <span> </span><span class="NLM_article-title">A quantitative assessment of hERG liability as a function of lipophilicity</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1759</span>– <span class="NLM_lpage">1764</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2Fj.bmcl.2006.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=17239590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1759-1764&author=M.+J.+Waringauthor=C.+Johnstone&title=A+quantitative+assessment+of+hERG+liability+as+a+function+of+lipophilicity&doi=10.1016%2Fj.bmcl.2006.12.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative assessment of hERG liability as a function of lipophilicity</span></div><div class="casAuthors">Waring, Michael J.; Johnstone, Craig</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1759-1764</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The impact of lipophilicity as a factor contributing to hERG potency is assessed for a large dataset of compds. of differing ionization type.  This dataset is derived from compds. tested in the Ionworks-based in vitro electrophysiol. hERG assay at AstraZeneca.  Using logistic regression, a quantification of the risk assocd. with increasing lipophilicity is presented.  The anticipated differences between acidic, basic and neutral compds. are apparent in the data but lipophilicity is shown to be a stronger driver for hERG potency than might have been expected.  Simple rules defining target lipophilicity values for minimizing hERG liability are derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlCr9mVGL2-LVg90H21EOLACvtfcHk0ljq0yzkR55anQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXit1yrtb8%253D&md5=3819e045d7b773f129773f1ff567b980</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DC.%26atitle%3DA%2520quantitative%2520assessment%2520of%2520hERG%2520liability%2520as%2520a%2520function%2520of%2520lipophilicity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1759%26epage%3D1764%26doi%3D10.1016%2Fj.bmcl.2006.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> cLogP values for the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> were calculated using Biobyte
software (<a href="http://www.biobyte.com" class="extLink">www.biobyte.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+cLogP+values+for+the+compounds+in+Table+2+were+calculated+using+Biobyte%0Asoftware+%28www.biobyte.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kunishima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawachi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwasaki, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tani, S.</span></span> <span> </span><span class="NLM_article-title">4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-morpholinium chloride: an efficient condensing agent leading to the formation of amides and esters</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">13159</span>– <span class="NLM_lpage">13170</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(99)00809-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2FS0040-4020%2899%2900809-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADyaK1MXntV2qtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=13159-13170&author=M.+Kunishimaauthor=C.+Kawachiauthor=J.+Montaauthor=K.+Teraoauthor=F.+Iwasakiauthor=S.+Tani&title=4-%284%2C6-dimethoxy-1%2C3%2C5-triazin-2-yl%29-4-methyl-morpholinium+chloride%3A+an+efficient+condensing+agent+leading+to+the+formation+of+amides+and+esters&doi=10.1016%2FS0040-4020%2899%2900809-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride: an efficient condensing agent leading to the formation of amides and esters</span></div><div class="casAuthors">Kunishima, Munetaka; Kawachi, Chiho; Morita, Jun; Terao, Keiji; Iwasaki, Fumiaki; Tani, Shohei</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">13159-13170</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">4-(4,6-Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM) was quant. synthesized by the coupling of 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) and N-methylmorpholine (NMM) in THF, and characterized.  Condensation of carboxylic acids and amines by DMTMM proceeded effectively in THF to give the corresponding amides in good yields.  The corresponding esters can be obtained by esterification of carboxylic acids with DMTMM in methanol, ethanol, iso-Pr alc., or t-Bu alc. in the presence of NMM.  The amt. of alcs. can be reduced to a stoichiometric amt. by conducting the reaction in THF.  Since the reactions proceed under atm. conditions without drying of the solvent, and the co-product (4,6-dimethoxy-1,3,5-triazin-2(1H)-one) arising from DMTMM after condensation can be readily removed by extn., this method is a very practical one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKXgxk6cGvMLVg90H21EOLACvtfcHk0liYmaRggdHUcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntV2qtb0%253D&md5=ffff2540367541c869f4661cb6407267</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2899%2900809-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252899%252900809-1%26sid%3Dliteratum%253Aachs%26aulast%3DKunishima%26aufirst%3DM.%26aulast%3DKawachi%26aufirst%3DC.%26aulast%3DMonta%26aufirst%3DJ.%26aulast%3DTerao%26aufirst%3DK.%26aulast%3DIwasaki%26aufirst%3DF.%26aulast%3DTani%26aufirst%3DS.%26atitle%3D4-%25284%252C6-dimethoxy-1%252C3%252C5-triazin-2-yl%2529-4-methyl-morpholinium%2520chloride%253A%2520an%2520efficient%2520condensing%2520agent%2520leading%2520to%2520the%2520formation%2520of%2520amides%2520and%2520esters%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D13159%26epage%3D13170%26doi%3D10.1016%2FS0040-4020%2899%2900809-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allison, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mani, N. S.</span></span> <span> </span><span class="NLM_article-title">Gram-scale synthesis of a beta-secretase 1 (BACE 1) inhibitor</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1021/acsomega.6b00362</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.6b00362" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=397-408&author=B.+D.+Allisonauthor=N.+S.+Mani&title=Gram-scale+synthesis+of+a+beta-secretase+1+%28BACE+1%29+inhibitor&doi=10.1021%2Facsomega.6b00362"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsomega.6b00362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.6b00362%26sid%3Dliteratum%253Aachs%26aulast%3DAllison%26aufirst%3DB.%2BD.%26aulast%3DMani%26aufirst%3DN.%2BS.%26atitle%3DGram-scale%2520synthesis%2520of%2520a%2520beta-secretase%25201%2520%2528BACE%25201%2529%2520inhibitor%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26spage%3D397%26epage%3D408%26doi%3D10.1021%2Facsomega.6b00362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">May, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dean, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martenyi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehan, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monk, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathes, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mergott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stout, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timm, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith LaBell, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhee, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ereshefsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calligaro, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocke, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hall, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedrich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Citron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">16507</span>– <span class="NLM_lpage">16516</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0liYmaRggdHUcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLaBell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman Rogers, M.</span></span> <i>Lilly Halts Phase 2 Trial of BACE Inhibitor Due to Liver Toxicity</i>; <span class="NLM_publisher-name">Alzforum</span>, <span class="NLM_year">2013</span>; <a href="https://www.alzforum.org/news/research-news/lilly-halts-phase-2-trial-bace-inhibitor-due-liver-toxicity" class="extLink">https://www.alzforum.org/news/research-news/lilly-halts-phase-2-trial-bace-inhibitor-due-liver-toxicity</a> (accessed May 7, 2018).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Bowman+Rogers&title=Lilly+Halts+Phase+2+Trial+of+BACE+Inhibitor+Due+to+Liver+Toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26aulast%3DBowman%2BRogers%26aufirst%3DM.%26jtitle%3DLilly%2520Halts%2520Phase%25202%2520Trial%2520of%2520BACE%2520Inhibitor%2520Due%2520to%2520Liver%2520Toxicity%26pub%3DAlzforum%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">O’Brien, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard-Cofield, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krejsa, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeline, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hougham, C.</span></span> <span> </span><span class="NLM_article-title">High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening</span>. <i>Arch. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">580</span>– <span class="NLM_lpage">604</span>, <span class="refDoi"> DOI: 10.1007/s00204-006-0091-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1007%2Fs00204-006-0091-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=16598496" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvVynurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=580-604&author=P.+J.+O%E2%80%99Brienauthor=W.+Irwinauthor=D.+Diazauthor=E.+Howard-Cofieldauthor=C.+M.+Krejsaauthor=M.+R.+Slaughterauthor=B.+Gaoauthor=N.+Kaludercicauthor=A.+Angelineauthor=P.+Bernardiauthor=P.+Brainauthor=C.+Hougham&title=High+concordance+of+drug-induced+human+hepatotoxicity+with+in+vitro+cytotoxicity+measured+in+a+novel+cell-based+model+using+high+content+screening&doi=10.1007%2Fs00204-006-0091-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening</span></div><div class="casAuthors">O'Brien, P. J.; Irwin, W.; Diaz, D.; Howard-Cofield, E.; Krejsa, C. M.; Slaughter, M. R.; Gao, B.; Kaludercic, N.; Angeline, A.; Bernardi, P.; Brain, P.; Hougham, C.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">580-604</span>CODEN:
                <span class="NLM_cas:coden">ARTODN</span>;
        ISSN:<span class="NLM_cas:issn">0340-5761</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">To develop and validate a practical, in vitro, cell-based model to assess human hepatotoxicity potential of drugs, we used the new technol. of high content screening (HCS) and a novel combination of crit. model features, including (1) use of live, human hepatocytes with drug metab. capability, (2) preincubation of cells for 3 days with drugs at a range of concns. up to at least 30 times the efficacious concn. or 100 μM, (3) measurement of multiple parameters that were (4) morphol. and biochem., (5) indicative of prelethal cytotoxic effects, (6) representative of different mechanisms of toxicity, (7) at the single cell level and (8) amenable to rapid throughput.  HCS is based on automated epifluorescence microscopy and image anal. of cells in a microtiter plate format.  The assay was applied to HepG2 human hepatocytes cultured in 96-well plates and loaded with four fluorescent dyes for: calcium (Fluo-4 AM), mitochondrial membrane potential (TMRM), DNA content (Hoechst 33342) to det. nuclear area and cell no. and plasma membrane permeability (TOTO-3).  Assay results were compared with those from 7 conventional, in vitro cytotoxicity assays that were applied to 611 compds. and shown to have low sensitivity (<25%), although high specificity (∼90%) for detection of toxic drugs.  For 243 drugs with varying degrees of toxicity, the HCS, sublethal, cytotoxicity assay had a sensitivity of 93% and specificity of 98%.  Drugs testing pos. that did not cause hepatotoxicity produced other serious, human organ toxicities.  For 201 pos. assay results, 86% drugs affected cell no., 70% affected nuclear area and mitochondrial membrane potential and 45% affected membrane permeability and 41% intracellular calcium concn.  Cell no. was the first parameter affected for 56% of these drugs, nuclear area for 34% and mitochondrial membrane potential for 29% and membrane permeability for 7% and intracellular calcium for 10%.  Hormesis occurred for 48% of all drugs with pos. response, for 26% of mitochondrial and 34% nuclear area changes and 12% of cell no. changes.  Pattern of change was dependent on the class of drug and mechanism of toxicity.  The ratio of concns. for in vitro cytotoxicity to maximal efficaciousness in humans was not different across groups (12±22).  Human toxicity potential was detected with 80% sensitivity and 90% specificity at a concn. of 30× the maximal efficacious concn. or 100 μM when efficaciousness was not considered.  We conclude that human hepatotoxicity is highly concordant with in vitro cytotoxicity in this novel model and as detected by HCS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroZK_xw9EaJrVg90H21EOLACvtfcHk0lgRNAA032ts2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvVynurc%253D&md5=84df3243f11d3309cf86a2f3f6160533</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs00204-006-0091-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00204-006-0091-3%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DP.%2BJ.%26aulast%3DIrwin%26aufirst%3DW.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DHoward-Cofield%26aufirst%3DE.%26aulast%3DKrejsa%26aufirst%3DC.%2BM.%26aulast%3DSlaughter%26aufirst%3DM.%2BR.%26aulast%3DGao%26aufirst%3DB.%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DAngeline%26aufirst%3DA.%26aulast%3DBernardi%26aufirst%3DP.%26aulast%3DBrain%26aufirst%3DP.%26aulast%3DHougham%26aufirst%3DC.%26atitle%3DHigh%2520concordance%2520of%2520drug-induced%2520human%2520hepatotoxicity%2520with%2520in%2520vitro%2520cytotoxicity%2520measured%2520in%2520a%2520novel%2520cell-based%2520model%2520using%2520high%2520content%2520screening%26jtitle%3DArch.%2520Toxicol.%26date%3D2006%26volume%3D80%26spage%3D580%26epage%3D604%26doi%3D10.1007%2Fs00204-006-0091-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pang, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, M.</span></span> <span> </span><span class="NLM_article-title">Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance</span>. <i>J. Pharmacokinet. Biopharm.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1007/BF01059688</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1007%2FBF01059688" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=599411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADyaE1cXhtFGjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1977&pages=625-653&author=K.+S.+Pangauthor=M.+Rowland&title=Hepatic+clearance+of+drugs.+I.+Theoretical+considerations+of+a+%E2%80%9Cwell-stirred%E2%80%9D+model+and+a+%E2%80%9Cparallel+tube%E2%80%9D+model.+Influence+of+hepatic+blood+flow%2C+plasma+and+blood+cell+binding%2C+and+the+hepatocellular+enzymatic+activity+on+hepatic+drug+clearance&doi=10.1007%2FBF01059688"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatic clearance of drugs.  I.  Theoretical considerations of a "well-stirred" model and a "parallel tube" model.  Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance</span></div><div class="casAuthors">Pang, K. Sandy; Rowland, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Biopharmaceutics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">625-53</span>CODEN:
                <span class="NLM_cas:coden">JPBPBJ</span>;
        ISSN:<span class="NLM_cas:issn">0090-466X</span>.
    </div><div class="casAbstract">Two commonly used models of hepatic drug clearance were examd.  The well-stirred model (model I) views the liver as a well-stirred compartment with concn. of drug in the liver in equil. with that in the emergent blood.  The parallel tube model (model II) regards the liver as a series of parallel tubes with enzymes distributed evenly around the tubes and the concn. of drug declining along the length of the tube.  Both models were examd. under steady-state considerations in the absence of diffusional limitations (i.e., cell membranes not limiting the movement of drug mols.).  Equations involving the determinants of hepatic drug clearance (hepatic blood flow, fraction of drug in blood unbound, and the hepatocellular enzymic activity) and various pharmacokinetic parameters were derived.  Similarities and differences between the models were explored.  Although both models predict similar hepatic drug clearances under a variety of conditions, marked differences between them become apparent in their predictions of the influence of changes in the determinants of drug clearance on various pharmacokinetic parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDpZaENZqfCbVg90H21EOLACvtfcHk0lgRNAA032ts2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhtFGjtLs%253D&md5=6a9e9bf46d9ce3571d8da77495cc9e19</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2FBF01059688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01059688%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DK.%2BS.%26aulast%3DRowland%26aufirst%3DM.%26atitle%3DHepatic%2520clearance%2520of%2520drugs.%2520I.%2520Theoretical%2520considerations%2520of%2520a%2520%25E2%2580%259Cwell-stirred%25E2%2580%259D%2520model%2520and%2520a%2520%25E2%2580%259Cparallel%2520tube%25E2%2580%259D%2520model.%2520Influence%2520of%2520hepatic%2520blood%2520flow%252C%2520plasma%2520and%2520blood%2520cell%2520binding%252C%2520and%2520the%2520hepatocellular%2520enzymatic%2520activity%2520on%2520hepatic%2520drug%2520clearance%26jtitle%3DJ.%2520Pharmacokinet.%2520Biopharm.%26date%3D1977%26volume%3D5%26spage%3D625%26epage%3D653%26doi%3D10.1007%2FBF01059688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rochin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurbain, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serneels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fort, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marks, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Strooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raposo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Niel, G.</span></span> <span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">10658</span>– <span class="NLM_lpage">10663</span>, <span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0liv0_lzJi_hVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Shimshek, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolly, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamurovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balavenkatraman, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morawiec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreutzer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schelle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jucker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertschi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theil, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigot, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beltz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machauer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brzak, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrot, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, U.</span></span> <span> </span><span class="NLM_article-title">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21917</span>, <span class="refDoi"> DOI: 10.1038/srep21917</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1038%2Fsrep21917" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=26912421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=21917&author=D.+R.+Shimshekauthor=L.+H.+Jacobsonauthor=C.+Kollyauthor=N.+Zamurovicauthor=K.+K.+Balavenkatramanauthor=L.+Morawiecauthor=R.+Kreutzerauthor=J.+Schelleauthor=M.+Juckerauthor=B.+Bertschiauthor=D.+Theilauthor=A.+Heierauthor=K.+Bigotauthor=K.+Beltzauthor=R.+Machauerauthor=I.+Brzakauthor=L.+Perrotauthor=U.+Neumann&title=Pharmacological+BACE1+and+BACE2+inhibition+induces+hair+depigmentation+by+inhibiting+PMEL17+processing+in+mice&doi=10.1038%2Fsrep21917"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice</span></div><div class="casAuthors">Shimshek, Derya R.; Jacobson, Laura H.; Kolly, Carine; Zamurovic, Natasa; Balavenkatraman, Kamal Kumar; Morawiec, Laurent; Kreutzer, Robert; Schelle, Juliane; Jucker, Mathias; Bertschi, Barbara; Theil, Diethilde; Heier, Annabelle; Bigot, Karine; Beltz, Karen; Machauer, Rainer; Brzak, Irena; Perrot, Ludovic; Neumann, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21917</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Melanocytes of the hair follicle produce melanin and are essential in detg. the differences in hair color.  Pigment cell-specific MELanocyte Protein (PMEL17) plays a crucial role in melanogenesis.  One of the crit. steps is the amyloid-like functional oligomerization of PMEL17.  Beta Site APP Cleaving Enzyme-2 (BACE2) and γ-secretase have been shown to be key players in generating the proteolytic fragments of PMEL17.  The β-secretase (BACE1) is responsible for the generation of amyloid-β (Aβ) fragments in the brain and is therefore proposed as a therapeutic target for Alzheimer's disease (AD).  Currently BACE1 inhibitors, most of which lack selectivity over BACE2, have demonstrated efficacious redn. of amyloid-β peptides in animals and the CSF of humans.  BACE2 knock-out mice have a deficiency in PMEL17 proteolytic processing leading to impaired melanin storage and hair depigmentation.  Here, we confirm BACE2-mediated inhibition of PMEL17 proteolytic processing in vitro in mouse and human melanocytes.  Furthermore, we show that wildtype as well as bace2+/- and bace2-/- mice treated with a potent dual BACE1/BACE2 inhibitor NB-360 display dose-dependent appearance of irreversibly depigmented hair.  Retinal pigmented epithelium showed no morphol. changes.  Our data demonstrates that BACE2 as well as addnl. BACE1 inhibition affects melanosome maturation and induces hair depigmentation in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtlQ-3Lxc4CLVg90H21EOLACvtfcHk0liv0_lzJi_hVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1eku7Y%253D&md5=e3641d48cc7fcf08c4502b5899a49066</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1038%2Fsrep21917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep21917%26sid%3Dliteratum%253Aachs%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26aulast%3DKolly%26aufirst%3DC.%26aulast%3DZamurovic%26aufirst%3DN.%26aulast%3DBalavenkatraman%26aufirst%3DK.%2BK.%26aulast%3DMorawiec%26aufirst%3DL.%26aulast%3DKreutzer%26aufirst%3DR.%26aulast%3DSchelle%26aufirst%3DJ.%26aulast%3DJucker%26aufirst%3DM.%26aulast%3DBertschi%26aufirst%3DB.%26aulast%3DTheil%26aufirst%3DD.%26aulast%3DHeier%26aufirst%3DA.%26aulast%3DBigot%26aufirst%3DK.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DBrzak%26aufirst%3DI.%26aulast%3DPerrot%26aufirst%3DL.%26aulast%3DNeumann%26aufirst%3DU.%26atitle%3DPharmacological%2520BACE1%2520and%2520BACE2%2520inhibition%2520induces%2520hair%2520depigmentation%2520by%2520inhibiting%2520PMEL17%2520processing%2520in%2520mice%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D21917%26doi%3D10.1038%2Fsrep21917" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cebers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attalla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budd Haeberlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugler, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingersoll, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, C. W.</span></span> <span> </span><span class="NLM_article-title">Reversible and species-specific depigmentation effects of AZD3293, a BACE inhibitor for the treatment of Alzheimer’s disease, are related to BACE2 inhibition and confined to epidermis and hair</span>. <i>J. Prev. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.14283/jpad.2016.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.14283%2Fjpad.2016.119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=201-218&author=G.+Cebersauthor=T.+Lejeuneauthor=B.+Attallaauthor=M.+Soderbergauthor=R.+C.+Alexanderauthor=S.+Budd+Haeberleinauthor=A.+R.+Kuglerauthor=E.+W.+Ingersollauthor=S.+Platzauthor=C.+W.+Scott&title=Reversible+and+species-specific+depigmentation+effects+of+AZD3293%2C+a+BACE+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+are+related+to+BACE2+inhibition+and+confined+to+epidermis+and+hair&doi=10.14283%2Fjpad.2016.119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.14283%2Fjpad.2016.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.14283%252Fjpad.2016.119%26sid%3Dliteratum%253Aachs%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DLejeune%26aufirst%3DT.%26aulast%3DAttalla%26aufirst%3DB.%26aulast%3DSoderberg%26aufirst%3DM.%26aulast%3DAlexander%26aufirst%3DR.%2BC.%26aulast%3DBudd%2BHaeberlein%26aufirst%3DS.%26aulast%3DKugler%26aufirst%3DA.%2BR.%26aulast%3DIngersoll%26aufirst%3DE.%2BW.%26aulast%3DPlatz%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DC.%2BW.%26atitle%3DReversible%2520and%2520species-specific%2520depigmentation%2520effects%2520of%2520AZD3293%252C%2520a%2520BACE%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520are%2520related%2520to%2520BACE2%2520inhibition%2520and%2520confined%2520to%2520epidermis%2520and%2520hair%26jtitle%3DJ.%2520Prev.%2520Alzheimers%2520Dis.%26date%3D2016%26volume%3D3%26spage%3D201%26epage%3D218%26doi%3D10.14283%2Fjpad.2016.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gee, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maron, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">Detection and classification of mutagens: a set of base-specific Salmonella tester strains</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">11606</span>– <span class="NLM_lpage">11610</span>, <span class="refDoi"> DOI: 10.1073/pnas.91.24.11606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1073%2Fpnas.91.24.11606" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=11606-11610&author=P.+Geeauthor=D.+M.+Maronauthor=B.+N.+Ames&title=Detection+and+classification+of+mutagens%3A+a+set+of+base-specific+Salmonella+tester+strains&doi=10.1073%2Fpnas.91.24.11606"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.91.24.11606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.91.24.11606%26sid%3Dliteratum%253Aachs%26aulast%3DGee%26aufirst%3DP.%26aulast%3DMaron%26aufirst%3DD.%2BM.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3DDetection%2520and%2520classification%2520of%2520mutagens%253A%2520a%2520set%2520of%2520base-specific%2520Salmonella%2520tester%2520strains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D11606%26epage%3D11610%26doi%3D10.1073%2Fpnas.91.24.11606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mesens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steemans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verheyen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanparys, P.</span></span> <span> </span><span class="NLM_article-title">A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase</span>. <i>Toxicol. in Vitro</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2008.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1016%2Fj.tiv.2008.11.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=217-226&author=N.+Mesensauthor=M.+Steemansauthor=E.+Hansenauthor=A.+Petersauthor=G.+Verheyenauthor=P.+Vanparys&title=A+96-well+flow+cytometric+screening+assay+for+detecting+in+vitro+phospholipidosis-induction+in+the+drug+discovery+phase&doi=10.1016%2Fj.tiv.2008.11.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2008.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2008.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DMesens%26aufirst%3DN.%26aulast%3DSteemans%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DE.%26aulast%3DPeters%26aufirst%3DA.%26aulast%3DVerheyen%26aufirst%3DG.%26aulast%3DVanparys%26aufirst%3DP.%26atitle%3DA%252096-well%2520flow%2520cytometric%2520screening%2520assay%2520for%2520detecting%2520in%2520vitro%2520phospholipidosis-induction%2520in%2520the%2520drug%2520discovery%2520phase%26jtitle%3DToxicol.%2520in%2520Vitro%26date%3D2009%26volume%3D23%26spage%3D217%26epage%3D226%26doi%3D10.1016%2Fj.tiv.2008.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ploemen, J.-P. H. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Sandt, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Burgsteden, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salemink, P. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van
Esch, E.</span></span> <span> </span><span class="NLM_article-title">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span>. <i>Exp. Toxicol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1078/0940-2993-00338</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1078%2F0940-2993-00338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=15088636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=347-355&author=J.-P.+H.+T.+M.+Ploemenauthor=J.+Kelderauthor=T.+Hafmansauthor=H.+Van+de+Sandtauthor=J.+A.+Van+Burgstedenauthor=P.+J.+M.+Saleminkauthor=E.+Van%0AEsch&title=Use+of+physicochemical+calculation+of+pKa+and+CLogP+to+predict+phospholipidosis-inducing+potential%3A+a+case+study+with+structurally+related+piperazines&doi=10.1078%2F0940-2993-00338"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines</span></div><div class="casAuthors">Ploemen, Jan-Peter H. T. M.; Kelder, Jan; Hafmans, Theo; van de Sandt, Han; van Burgsteden, Johan A.; Salemink, Paul J. M.; van Esch, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">347-355</span>CODEN:
                <span class="NLM_cas:coden">ETPAEK</span>;
        ISSN:<span class="NLM_cas:issn">0940-2993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Several cationic amphiphilic compds. are known to induce phospholipidosis, a condition primarily characterized by excessive accumulation of phospholipids in different cell types, giving the affected cells a finely foamy appearance.  Excessive storage of lamellar membranous intralysosomal inclusion bodies is the hallmark for phospholipidosis on the electron microscopic level.  In case of alveolar phospholipidosis, foamy macrophages accumulate within the alveolar spaces of the lung.  Based on such findings in a one-year toxicity study with gepirone in rats, we studied the mol. properties of this compd. and compds. suspected of being phospholipidosis inducers by means of physicochem. calcns.  Physicochem. mol. calcns. of mol. wt., ClogP (partition coeff. octanol/water), logD at pH 7.4, and pKa were performed, for the cationic amphiphilic compds. chlorpromazine, amiodarone, imipramine, propranolol and fluoxetine, and for the structurally related compds. 1-phenylpiperazine (1-PHP), gepirone (and its major metabolites, 3-OH-gepirone and 1-pyrimidinylpiperazine [1-PP]), and buspirone.  ClogP and calcd. pKa cluster differently for the amphiphilic drugs compared to the chem. series of piperazines.  In line with this anal., lamellar inclusion bodies were found in an in vitro validation expt. in the human monoblastoid cell line U-937, incubated for 96 h at 10 μg/mL with cationic amphiphilic drugs (amiodarone, imipramine, or propranolol).  No such lamellar inclusion bodies were seen for any of the compds. from the chem. series of piperazines including gepirone and its metabolites.  The data presented support the use of simple physicochem. calcns. of ClogP and pKa to discriminate rapidly between compds. suspected of being phospholipidosis inducers.  Finally, the discriminative power of these physicochem. ClogP and pKa calcns. to predict phospholipidosis-inducing potential was further validated by extension of the set of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-qnA3_zghvbVg90H21EOLACvtfcHk0liZOC9J029Ldw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFGltL0%253D&md5=caf5e68d3d5356dfef1cc29dbaf5ca87</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1078%2F0940-2993-00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1078%252F0940-2993-00338%26sid%3Dliteratum%253Aachs%26aulast%3DPloemen%26aufirst%3DJ.-P.%2BH.%2BT.%2BM.%26aulast%3DKelder%26aufirst%3DJ.%26aulast%3DHafmans%26aufirst%3DT.%26aulast%3DVan%2Bde%2BSandt%26aufirst%3DH.%26aulast%3DVan%2BBurgsteden%26aufirst%3DJ.%2BA.%26aulast%3DSalemink%26aufirst%3DP.%2BJ.%2BM.%26aulast%3DVan%2BEsch%26aufirst%3DE.%26atitle%3DUse%2520of%2520physicochemical%2520calculation%2520of%2520pKa%2520and%2520CLogP%2520to%2520predict%2520phospholipidosis-inducing%2520potential%253A%2520a%2520case%2520study%2520with%2520structurally%2520related%2520piperazines%26jtitle%3DExp.%2520Toxicol.%2520Pathol.%26date%3D2004%26volume%3D55%26spage%3D347%26epage%3D355%26doi%3D10.1078%2F0940-2993-00338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hanumegowda, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regueiro-Ren, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yordanova, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corradi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S. P.</span></span> <span> </span><span class="NLM_article-title">Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">749</span>– <span class="NLM_lpage">755</span>, <span class="refDoi"> DOI: 10.1021/tx9003825</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx9003825" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVeqtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2010&pages=749-755&author=U.+M.+Hanumegowdaauthor=G.+Wenkeauthor=A.+Regueiro-Renauthor=R.+Yordanovaauthor=J.+P.+Corradiauthor=S.+P.+Adams&title=Phospholipidosis+as+a+function+of+basicity%2C+lipophilicity%2C+and+volume+of+distribution+of+compounds&doi=10.1021%2Ftx9003825"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds</span></div><div class="casAuthors">Hanumegowda, Umesh M.; Wenke, Gottfried; Regueiro-Ren, Alicia; Yordanova, Roumyana; Corradi, John P.; Adams, Stephen P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Drug-induced phospholipidosis (PLD) is an adaptive histol. alteration that is seen with various marketed drugs and often encountered during drug development.  Various in silico and in vitro cell-based methods have been developed to predict the PLD-inducing potential of compds.  These methods rely on the inherent physicochem. properties of the mol. and, as such, tend to overpredict compds. as PLD inducers.  Recognizing that the distribution of compds. into tissues or tissue accumulation is likely a key factor in PLD induction, in addn. to key physicochem. properties, we developed a model to predict PLD in vivo using the measures of basicity (pKa), lipophilicity (ClogP), and vol. of distribution (Vd).  Using sets of PLD inducers and noninducers, we demonstrate improved concordance with this method.  Furthermore, we propose a screening paradigm that includes a combination of various methods to predict the in vivo PLD-inducing potential of compds., which may be esp. useful in lead identification and optimization processes in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJNq2nVkAysrVg90H21EOLACvtfcHk0liZOC9J029Ldw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVeqtLw%253D&md5=471380f65644ba0db549660acf6b4d8d</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Ftx9003825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx9003825%26sid%3Dliteratum%253Aachs%26aulast%3DHanumegowda%26aufirst%3DU.%2BM.%26aulast%3DWenke%26aufirst%3DG.%26aulast%3DRegueiro-Ren%26aufirst%3DA.%26aulast%3DYordanova%26aufirst%3DR.%26aulast%3DCorradi%26aufirst%3DJ.%2BP.%26aulast%3DAdams%26aufirst%3DS.%2BP.%26atitle%3DPhospholipidosis%2520as%2520a%2520function%2520of%2520basicity%252C%2520lipophilicity%252C%2520and%2520volume%2520of%2520distribution%2520of%2520compounds%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2010%26volume%3D23%26spage%3D749%26epage%3D755%26doi%3D10.1021%2Ftx9003825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Broeck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tréton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopf, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsden, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, A.</span></span> <span> </span><span class="NLM_article-title">Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer’s disease</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">375</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01207.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=10.1111%2Fj.1476-5381.2011.01207.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=21232036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1GitL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=375-389&author=B.+Van%0ABroeckauthor=J.-M.+Chenauthor=G.+Tr%C3%A9tonauthor=M.+Desmidtauthor=C.+Hopfauthor=N.+Ramsdenauthor=E.+Karranauthor=M.+Merckenauthor=A.+Rowley&title=Chronic+treatment+with+a+novel+%CE%B3-secretase+modulator%2C+JNJ-40418677%2C+inhibits+amyloid+plaque+formation+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fj.1476-5381.2011.01207.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Van Broeck, B.; Chen, J.-M.; Treton, G.; Desmidt, M.; Hopf, C.; Ramsden, N.; Karran, E.; Mercken, M.; Rowley, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">375-389</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">γ-Secretase modulators represent a promising therapeutic approach for Alzheimer's disease (AD) because they selectively decrease amyloid β 42 (Aβ42), a particularly neurotoxic Aβ species that accumulates in plaques in the brains of patients with AD.  In the present study, we describe the in vitro and in vivo pharmacol. properties of a potent novel γ-secretase modulator, 2-(S)-(3,5-bis(4-(trifluoromethyl)phenyl)phenyl)-4-methylpentanoic acid (JNJ-40418677).  The potency and selectivity of JNJ-40418677 for Aβ redn. was investigated in human neuroblastoma cells, rat primary neurons and after treatment with single oral doses in non-transgenic mouse brains.  To evaluate the effect of JNJ-40418677 on plaque formation, Tg2576 mice were treated from 6 until 13 mo of age via the diet.  JNJ-40418677 selectively reduced Aβ42 secretion in human neuroblastoma cells and rat primary neurons, but it did not inhibit Notch processing or formation of other amyloid precursor protein cleavage products.  Oral treatment of non-transgenic mice with JNJ-40418677 resulted in an excellent brain penetration of the compd. and a dose- and time-dependent decrease of brain Aβ42 levels.  Chronic treatment of Tg2576 mice with JNJ-40418677 reduced brain Aβ levels, the area occupied by plaques and plaque no. in a dose-dependent manner compared with transgenic vehicle-treated mice.  JNJ-40418677 selectively decreased Aβ42 prodn., showed an excellent brain penetration after oral administration in mice and lowered brain Aβ burden in Tg2576 mice after chronic treatment.  JNJ-40418677 therefore warrants further investigation as a potentially effective disease-modifying therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7MGWYryyTFbVg90H21EOLACvtfcHk0ljmAiHjwtAyxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1GitL0%253D&md5=aae5e894472fc12258ef3e4662a726e4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01207.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01207.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BBroeck%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DJ.-M.%26aulast%3DTr%25C3%25A9ton%26aufirst%3DG.%26aulast%3DDesmidt%26aufirst%3DM.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DRamsden%26aufirst%3DN.%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DRowley%26aufirst%3DA.%26atitle%3DChronic%2520treatment%2520with%2520a%2520novel%2520%25CE%25B3-secretase%2520modulator%252C%2520JNJ-40418677%252C%2520inhibits%2520amyloid%2520plaque%2520formation%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26spage%3D375%26epage%3D389%26doi%3D10.1111%2Fj.1476-5381.2011.01207.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i41"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00304">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_24864"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00304">10.1021/acs.jmedchem.8b00304</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">All additional pharmacological profiling protocols: hERG patch-clamp; microsomal metabolic stability; hepatocyte metabolic stability; CYP450 inhibition; plasma protein binding; nonspecific binding to brain tissue; in vitro permeability/P-gp efflux; p<i>K</i><sub>a</sub> and log <i>D</i> assay; high content screen cytotoxicity assay with HepG2-cells; in vitro phospholipidosis; in vitro selectivity profile (CEREP); in vivo PK and toxicology studies: PK studies in mouse, rat, and dog; cardio-hemodynamic and cardio-electrophysiological effects in anesthetized guinea pigs; one-month GLP toxicity studies; <sup>1</sup>H-NOESY and <sup>19</sup>F-<sup>1</sup>H NOESY data for <b>25</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_001.pdf">PDF</a>)</p></li><li><p class="inline">List of molecular formula strings and the associated biochemical and biological data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_001.pdf">jm8b00304_si_001.pdf (654.01 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00304/suppl_file/jm8b00304_si_002.csv">jm8b00304_si_002.csv (2.23 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00304&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-12%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00304%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00304" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996b5cb8a224cb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
